自由君的个人主页 - 老虎社区

自由君

自由君

暂无个人介绍

IP属地：北京

21关注

1粉丝

4主题

0勋章

03-06

鸡你太美就等着开源呢

得不到就毁掉？OpenAI驳回马斯克的所有指控

2021-09-08

特斯拉上海工厂大多数产能都出口欧洲市场，等该死的德国工厂建成出产能就是血洗国内三傻的时候！

乘联会：特斯拉中国8月销售44264辆，比亚迪60858辆

2021-08-13

华为拷贝部马上加班拷贝[开心]

苹果新专利：把Apple Pencil放在电脑里

2021-05-21

滑而不为，徒有其名

华为将扩大与长安汽车的智能汽车合作伙伴关系，以研发芯片

2021-05-06

蟑狼要被气哭，销量怎么还这么好😄

外媒：特斯拉需求异常强劲，第二季度产能已经售罄

2021-05-03

$华仕伯(VAL)$终于重组成功了！有票的兄弟是不是被清零了？

2021-02-08

格局限制，也只能做国内的B站

抱歉，原内容已删除

2021-01-04

台积电2021年产能铺满，没有多余产能了

ASML传来坏消息！张忠谋：国产光刻机迎来磨难，台积电首当其冲

2020-12-04

$壹传媒(00282)$又涨了[笑哭]

2020-10-20

$华仕伯(VAL)$怎么从退市变成停牌了？

2020-09-16

这篇文章不错，转发给大家看看

There are seven coronavirus vaccine candidates being tested in the U.S. -- here's where they stand

2020-09-02

$Whiting Petroleum Corp(WLL)$总股本未变，不是75股变1股吗？

2020-07-01

$景顺抵押资本(IVR)$确定过信息，被套路了[捂脸]

2020-05-22

割韭菜

抱歉，原内容已删除

2020-04-27

$MFA Financial(MFA)$$景顺抵押资本(IVR)$这个有利好吗？

2020-04-03

$MFA Financial(MFA)$出了什么事，怎么突然涨起来了？

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3547114025989487","uuid":"3547114025989487","gmtCreate":1584217311252,"gmtModify":1620054380474,"name":"自由君","pinyin":"zyjziyoujun","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":21,"tweetSize":16,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":4,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.04.24","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.21%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.97%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"北京","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":281246745047152,"gmtCreate":1709694273768,"gmtModify":1709694275503,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"鸡你太美就等着开源呢","listText":"鸡你太美就等着开源呢","text":"鸡你太美就等着开源呢","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/281246745047152","repostId":"1163823659","repostType":2,"repost":{"id":"1163823659","pubTimestamp":1709692916,"share":"https://www.laohu8.com/m/news/1163823659?lang=&edition=full","pubTime":"2024-03-06 10:41","market":"us","language":"zh","title":"得不到就毁掉？OpenAI驳回马斯克的所有指控","url":"https://stock-news.laohu8.com/highlight/detail?id=1163823659","media":"华尔街见闻","summary":"马斯克一直都理解OpenAI要实现使命并不意味着需要开源。","content":"<html><head></head><body><p>作者：葛佳明</p><p>OpenAI与马斯克间大战升级，持续白热化！OpenAI在其官网发布博文正式回应，<strong>“驳回马斯克所有主张”</strong>。</p><p style=\"text-align: justify;\">3月1日马斯克一纸诉状，把OpenAI和CEO兼联合创始人山姆·奥特曼、格雷格·布罗克曼告上法庭，从2015年联合创立OpenAI到对簿公堂，46页的上诉书将矛盾聚焦在了“非营利性”和“开源”两个词上，声称OpenAI违反协议，开发技术是为了造福人类而不是利润，要求奥特曼还钱。</p><p style=\"text-align: justify;\">就在刚刚，OpenAI 用一篇长文《OpenAI and Elon Musk》，正式驳斥了马斯克的所有指控，放出自2015年来与马斯克的详细邮件来往，回应了三点：</p><p style=\"text-align: justify;\"><strong>1.构建AGI将需要比最初想象的更多的资源；</strong></p><p style=\"text-align: justify;\"><strong>2.OpenAI和马斯克认识到需要一个营利性实体来获取这些资源；</strong></p><p style=\"text-align: justify;\"><strong>3. OpenAI的Open意味每个人都应该享有AI带来的成果，不是开源。</strong></p><p style=\"text-align: justify;\">来看最重要的三点，OpenAI表示，<strong>马斯克因未能享受到OpenAI的成果而不满，所以提起诉讼，</strong>AGI所需的投入比设想的要多，<strong>当初双方都认可构建一个营利性实体的必要性，但马斯克曾想控制公司让其与特斯拉合并，未能成功，却在OpenAI取得成果了以后提起了诉讼</strong>：</p><blockquote><p style=\"text-align: justify;\">构建通用人工智能（AGI）所需要的资源和投入比最初设想的还要多，而公司和马斯克都意识到，要获得这些资源，构建一个营利性实体是必要的，但我们无法就营利实体的条款与他达成协议。</p><p style=\"text-align: justify;\">我们认为<strong>任何个人对OpenAI拥有绝对控制权都有悖于我们的使命，</strong>之后他提议将OpenAI并入特斯拉。2018年2月初马斯克的邮件称，建议OpenAI&#34;<strong>并入特斯拉作为它的现金奶牛&#34;</strong>，他认为“这一决定是完全正确的......加入特斯拉是OpenAI唯一能与谷歌争锋选择。”</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/fc834195404c235b6a2fc999b6b90f12\" tg-width=\"640\" tg-height=\"299\"/></p></blockquote><p style=\"text-align: justify;\">OpenAI称，<strong>马斯克一直都理解OpenAI要实现使命并不意味着需要开源，Open意味每个人都应该享有AI带来的成果，正如下图Ilya和马斯克的对话:</strong></p><blockquote><p style=\"text-align: justify;\">实际上开源可能会增加风险，随着我们距离构建AI愈来越近，保持不那么开放或许会更有意义。OpenAI中的Open意味着每个人都应该享有AI带来的成果，但着并不意味着必须公开分享所有科学研究和技术细节，特别是在接近实现AI技术的关键阶段。马斯克回复为:“是的”。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/90c9ff1a2c17da6e7b437fc267c14a8a\" tg-width=\"640\" tg-height=\"741\"/></p></blockquote><h2 id=\"id_2547319607\" style=\"text-align: start;\">未能并入特斯拉，马斯克急了？</h2><p style=\"text-align: justify;\">OpenAI直言，2015年底创办OpenAI时，马斯克就知道发展AI所需要的庞大资金支出，最初Greg Brockman和Sam Altman计划筹集1亿美元，但马斯克在一封电子邮件中表示，考虑到谷歌和Facebook的庞大指出规模，筹集的资金规模应达到10亿美元，不足的部分他会补足缺口：</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bf133fe7a5116aefadd50c17024ab918\" tg-width=\"640\" tg-height=\"617\"/></p><p style=\"text-align: justify;\">但建设AGI所需的资源成本远远超出了最初的设想，到了2017年底，OpenAI和马斯克<strong>都认识到，要获得这些资源，就必须建立一个营利实体，2018年初马斯克提议要让OpenAI加入特斯拉，但未能成功：</strong></p><blockquote><p style=\"text-align: justify;\">我们决定下一步的任务是创建一个营利实体，但埃隆希望获得多数股权、董事会控制权并担任首席执行官。我们没谈拢，他暂停了资金支持，Reid Hoffman填补了资金缺口，支付了工资和运营费用。</p><p style=\"text-align: justify;\">马斯克希望我们与特斯拉合并，作为特斯拉的“现金奶牛”，称加入特斯拉是OpenAI唯一能与谷歌争锋选择。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/88d45340c238e669b8d9a7f24be91677\" tg-width=\"640\" tg-height=\"598\"/></p></blockquote><p style=\"text-align: justify;\">因为OpenAI拒绝了马斯克加入特斯拉的协议，很快马斯克选择了离开，并直言OpenAI成功概率为0，计划在特斯拉内部建立一个能与之抗衡的AGI竞争对手：</p><blockquote><p style=\"text-align: justify;\">他在2018年2月底离开时告诉我们的团队，他支持我们未来自己寻找数十亿美元的资金来源，2018年12月，马斯克再次给我们发邮件说：“筹集到几亿美元也远远不够，AGI需要每年数十亿美元的投资，否则就别想了。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3f7a873f97b882604d366c583e49ae68\" tg-width=\"640\" tg-height=\"718\"/></p></blockquote><p style=\"text-align: justify;\">马斯克2016年向OpenAI资助超过1500万美元，高于其他捐赠者还要多，帮助OpenAI组成一支拥有顶尖人才的团队，次年又向OpenAI资助了近2000万美元。从2016年至2020年9月，马斯克共向OpenAI投资超过4400万美元。马斯克称为OpenAI租下最初办公室并支付租金，还强调他参与了公司重要里程碑。</p><p style=\"text-align: justify;\">OpenAI在公告中并未质疑马斯克在OpenAI成立初期的功劳称，他们深深钦佩的人竟然走到了这一步——曾激励OpenAI向更高的目标迈进，但却在OpenAI向着使命迈进时，起诉了他们：</p><blockquote><p style=\"text-align: justify;\">令我们深感遗憾的是，我们深深钦佩的一个人竟然走到了这一步——他激励我们向更高的目标迈进，然后告诉我们会失败，成立了一个竞争对手，当我们开始在没有他的情况下朝着 OpenAI 的使命取得有意义的进展时，他又起诉了我们。</p><p style=\"text-align: justify;\">我们专注于推进我们的使命，还有很长的路要走。随着我们不断改进我们的工具，我们很高兴能够部署这些系统，以便它们赋予每个人力量。</p></blockquote><p style=\"text-align: justify;\">但很显然，马斯克在2018年对于OpenAI的预测被现实“打脸”。</p><p style=\"text-align: justify;\">当ChatGPT于11月推出时，OpenAI立即成为最热门的新科技初创公司，迫使谷歌争相追赶。对此马斯克非常愤怒。12月马斯克违背了收购推特之前签署的合同，取消了OpenAI对推特“水管”数据流的访问。</p><p style=\"text-align: justify;\">去年2月17日，马斯克在X上写道：“OpenAI是作为一家开源的非营利公司创建的，以制衡谷歌，但现在它却已经成为一家由微软有效控制的开源、利润最大的公司。”</p><p style=\"text-align: justify;\">3月15日，他在X上再次发文：“我仍然很困惑，我捐赠了约1亿美元的非营利组织是如何变成300亿美元的市值营利组织的。如果这是合法的，为什么不让其他人这样做？”</p><p style=\"text-align: justify;\">周五，他又推发布了“我相信一切都会好起来的”，却在一个表情包中写道：“我意识到人工智能，人类有史以来最强大的工具，现在掌握在无情的企业垄断手中。”</p><p style=\"text-align: justify;\">因此有分析认为，或许马斯克和OpenAI之间的纠纷与其是否营利实体的地位无关。</p><p style=\"text-align: justify;\">OpenAI将谷歌甩在了身后，无疑深深刺痛了当年离开的马斯克，使他与如今科技界最热闹的事情毫无关系。马斯克现在的目标是创办自己的人工智能初创公司。但他如今还将背负着推特这一代价高昂的“消遣”。</p><h2 id=\"id_1079109282\" style=\"text-align: start;\">One More Thing</h2><p style=\"text-align: justify;\">OpenAI的公开回应引爆了社交圈，大家还注意到了双方邮件中的一句话，“不幸的是，人类的未来掌握在xxx的手上。”网友纷纷猜测■■■中是谁？谷歌吗？</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/58ac082c15ae833ed92ef4a8ce1981a9\" tg-width=\"640\" tg-height=\"266\"/></p></body></html>","source":"live_wallstreetcn","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>得不到就毁掉？OpenAI驳回马斯克的所有指控</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n得不到就毁掉？OpenAI驳回马斯克的所有指控\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-06 10:41 北京时间&nbsp;&nbsp;&nbsp;<a href=https://wallstreetcn.com/articles/3709765><strong>华尔街见闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>作者：葛佳明OpenAI与马斯克间大战升级，持续白热化！OpenAI在其官网发布博文正式回应，“驳回马斯克所有主张”。3月1日马斯克一纸诉状，把OpenAI和CEO兼联合创始人山姆·奥特曼、格雷格·布罗克曼告上法庭，从2015年联合创立OpenAI到对簿公堂，46页的上诉书将矛盾聚焦在了“非营利性”和“开源”两个词上，声称OpenAI违反协议，开发技术是为了造福人类而不是利润，要求奥特曼还钱。就在...</p>\n\n<a href=\"https://wallstreetcn.com/articles/3709765\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/7c27753f957ea65b9ef23911f49354be","relate_stocks":{},"source_url":"https://wallstreetcn.com/articles/3709765","is_english":false,"share_image_url":"https://static.laohu8.com/cc96873d3d23ee6ac10685520df9c100","article_id":"1163823659","content_text":"作者：葛佳明OpenAI与马斯克间大战升级，持续白热化！OpenAI在其官网发布博文正式回应，“驳回马斯克所有主张”。3月1日马斯克一纸诉状，把OpenAI和CEO兼联合创始人山姆·奥特曼、格雷格·布罗克曼告上法庭，从2015年联合创立OpenAI到对簿公堂，46页的上诉书将矛盾聚焦在了“非营利性”和“开源”两个词上，声称OpenAI违反协议，开发技术是为了造福人类而不是利润，要求奥特曼还钱。就在刚刚，OpenAI 用一篇长文《OpenAI and Elon Musk》，正式驳斥了马斯克的所有指控，放出自2015年来与马斯克的详细邮件来往，回应了三点：1.构建AGI将需要比最初想象的更多的资源；2.OpenAI和马斯克认识到需要一个营利性实体来获取这些资源；3. OpenAI的Open意味每个人都应该享有AI带来的成果，不是开源。来看最重要的三点，OpenAI表示，马斯克因未能享受到OpenAI的成果而不满，所以提起诉讼，AGI所需的投入比设想的要多，当初双方都认可构建一个营利性实体的必要性，但马斯克曾想控制公司让其与特斯拉合并，未能成功，却在OpenAI取得成果了以后提起了诉讼：构建通用人工智能（AGI）所需要的资源和投入比最初设想的还要多，而公司和马斯克都意识到，要获得这些资源，构建一个营利性实体是必要的，但我们无法就营利实体的条款与他达成协议。我们认为任何个人对OpenAI拥有绝对控制权都有悖于我们的使命，之后他提议将OpenAI并入特斯拉。2018年2月初马斯克的邮件称，建议OpenAI\"并入特斯拉作为它的现金奶牛\"，他认为“这一决定是完全正确的......加入特斯拉是OpenAI唯一能与谷歌争锋选择。”OpenAI称，马斯克一直都理解OpenAI要实现使命并不意味着需要开源，Open意味每个人都应该享有AI带来的成果，正如下图Ilya和马斯克的对话:实际上开源可能会增加风险，随着我们距离构建AI愈来越近，保持不那么开放或许会更有意义。OpenAI中的Open意味着每个人都应该享有AI带来的成果，但着并不意味着必须公开分享所有科学研究和技术细节，特别是在接近实现AI技术的关键阶段。马斯克回复为:“是的”。未能并入特斯拉，马斯克急了？OpenAI直言，2015年底创办OpenAI时，马斯克就知道发展AI所需要的庞大资金支出，最初Greg Brockman和Sam Altman计划筹集1亿美元，但马斯克在一封电子邮件中表示，考虑到谷歌和Facebook的庞大指出规模，筹集的资金规模应达到10亿美元，不足的部分他会补足缺口：但建设AGI所需的资源成本远远超出了最初的设想，到了2017年底，OpenAI和马斯克都认识到，要获得这些资源，就必须建立一个营利实体，2018年初马斯克提议要让OpenAI加入特斯拉，但未能成功：我们决定下一步的任务是创建一个营利实体，但埃隆希望获得多数股权、董事会控制权并担任首席执行官。我们没谈拢，他暂停了资金支持，Reid Hoffman填补了资金缺口，支付了工资和运营费用。马斯克希望我们与特斯拉合并，作为特斯拉的“现金奶牛”，称加入特斯拉是OpenAI唯一能与谷歌争锋选择。因为OpenAI拒绝了马斯克加入特斯拉的协议，很快马斯克选择了离开，并直言OpenAI成功概率为0，计划在特斯拉内部建立一个能与之抗衡的AGI竞争对手：他在2018年2月底离开时告诉我们的团队，他支持我们未来自己寻找数十亿美元的资金来源，2018年12月，马斯克再次给我们发邮件说：“筹集到几亿美元也远远不够，AGI需要每年数十亿美元的投资，否则就别想了。马斯克2016年向OpenAI资助超过1500万美元，高于其他捐赠者还要多，帮助OpenAI组成一支拥有顶尖人才的团队，次年又向OpenAI资助了近2000万美元。从2016年至2020年9月，马斯克共向OpenAI投资超过4400万美元。马斯克称为OpenAI租下最初办公室并支付租金，还强调他参与了公司重要里程碑。OpenAI在公告中并未质疑马斯克在OpenAI成立初期的功劳称，他们深深钦佩的人竟然走到了这一步——曾激励OpenAI向更高的目标迈进，但却在OpenAI向着使命迈进时，起诉了他们：令我们深感遗憾的是，我们深深钦佩的一个人竟然走到了这一步——他激励我们向更高的目标迈进，然后告诉我们会失败，成立了一个竞争对手，当我们开始在没有他的情况下朝着 OpenAI 的使命取得有意义的进展时，他又起诉了我们。我们专注于推进我们的使命，还有很长的路要走。随着我们不断改进我们的工具，我们很高兴能够部署这些系统，以便它们赋予每个人力量。但很显然，马斯克在2018年对于OpenAI的预测被现实“打脸”。当ChatGPT于11月推出时，OpenAI立即成为最热门的新科技初创公司，迫使谷歌争相追赶。对此马斯克非常愤怒。12月马斯克违背了收购推特之前签署的合同，取消了OpenAI对推特“水管”数据流的访问。去年2月17日，马斯克在X上写道：“OpenAI是作为一家开源的非营利公司创建的，以制衡谷歌，但现在它却已经成为一家由微软有效控制的开源、利润最大的公司。”3月15日，他在X上再次发文：“我仍然很困惑，我捐赠了约1亿美元的非营利组织是如何变成300亿美元的市值营利组织的。如果这是合法的，为什么不让其他人这样做？”周五，他又推发布了“我相信一切都会好起来的”，却在一个表情包中写道：“我意识到人工智能，人类有史以来最强大的工具，现在掌握在无情的企业垄断手中。”因此有分析认为，或许马斯克和OpenAI之间的纠纷与其是否营利实体的地位无关。OpenAI将谷歌甩在了身后，无疑深深刺痛了当年离开的马斯克，使他与如今科技界最热闹的事情毫无关系。马斯克现在的目标是创办自己的人工智能初创公司。但他如今还将背负着推特这一代价高昂的“消遣”。One More ThingOpenAI的公开回应引爆了社交圈，大家还注意到了双方邮件中的一句话，“不幸的是，人类的未来掌握在xxx的手上。”网友纷纷猜测■■■中是谁？谷歌吗？","news_type":1},"isVote":1,"tweetType":1,"viewCount":738,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":889008878,"gmtCreate":1631088317794,"gmtModify":1631088317794,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"特斯拉上海工厂大多数产能都出口欧洲市场，等该死的德国工厂建成出产能就是血洗国内三傻的时候！","listText":"特斯拉上海工厂大多数产能都出口欧洲市场，等该死的德国工厂建成出产能就是血洗国内三傻的时候！","text":"特斯拉上海工厂大多数产能都出口欧洲市场，等该死的德国工厂建成出产能就是血洗国内三傻的时候！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/889008878","repostId":"1199548550","repostType":4,"repost":{"id":"1199548550","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631087792,"share":"https://www.laohu8.com/m/news/1199548550?lang=&edition=full","pubTime":"2021-09-08 15:56","market":"us","language":"zh","title":"乘联会：特斯拉中国8月销售44264辆，比亚迪60858辆","url":"https://stock-news.laohu8.com/highlight/detail?id=1199548550","media":"老虎资讯综合","summary":"乘联会：8月新能源乘用车批发销量达到30.4万辆，同比增长202.3%，环比增长23.7%。1-8月新能源乘用车批发164.3万辆，同比增长222.5%。8月新能源乘用车零售销量达到24.9万辆，同比","content":"<p>乘联会：8月新能源乘用车批发销量达到30.4万辆，同比增长202.3%，环比增长23.7%。1-8月新能源乘用车批发164.3万辆，同比增长222.5%。8月新能源乘用车零售销量达到24.9万辆，同比增长167.5%，环比增12.0%。1-8月新能源车零售147.9万辆，同比增长202.1%。与传统燃油车走势形成强烈差异化的特征，实现对燃油车市场的替代效应，并拉动车市向新能源化转型的步伐。</p>\n<p>乘联会数据显示，2021年8月乘用车市场零售达到145.3万辆，同比下降14.7%，而且相较2019年8月下降7%，增速偏弱。今年1-8月的零售累计达到1290.0万辆，同比增长17.1%，较1-7月增速下降6个百分点。减速的原因主要是2020年7-8月零售高基数的影响。今年1-8月同比增量188万辆中的新能源车增量就达100万辆，占总增量54% 对1-8月同比增速贡献了9个百分点。</p>\n<p>8月新能源车出口呈现爆发式增长，特斯拉中国出口31,379辆，上汽乘用车的新能源出口4,074辆，比亚迪781辆，爱驰汽车103辆，其他车企新能源车出口也正蓄势待发。2021年比利时成为中国最大汽车出口地。</p>\n<p>8月理想、小鹏、蔚来、合众、零跑等新势力车企销量同比和环比表现总体都很优秀，尤其是哪吒、零跑等二线新势力逐步崛起。主流合资品牌中的南北大众的新能源车批发11,756辆，占据主流合资69%份额。</p>\n<p>8月新能源乘用车市场多元化发力，大集团新能源表现分化，上汽、广汽表现相对较强。厂商批发销量突破万辆的企业有：比亚迪60,858辆、特斯拉中国44,264辆、上汽通用五菱43,783辆、上汽乘用车16,998辆、广汽埃安11,613辆。8月插电混动的比亚迪销量达到30,476辆，环比增长24%，推动平价插电混动增长成新亮点。</p>\n<p>乘联会：随着合资与豪华车企的芯片持续供给不足，加之新能源车的连续火爆，自主品牌的产销也将明显提升，体现了自主品牌供应链自主可控的产业优势。</p>\n<p></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>乘联会：特斯拉中国8月销售44264辆，比亚迪60858辆</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n乘联会：特斯拉中国8月销售44264辆，比亚迪60858辆\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-09-08 15:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>乘联会：8月新能源乘用车批发销量达到30.4万辆，同比增长202.3%，环比增长23.7%。1-8月新能源乘用车批发164.3万辆，同比增长222.5%。8月新能源乘用车零售销量达到24.9万辆，同比增长167.5%，环比增12.0%。1-8月新能源车零售147.9万辆，同比增长202.1%。与传统燃油车走势形成强烈差异化的特征，实现对燃油车市场的替代效应，并拉动车市向新能源化转型的步伐。</p>\n<p>乘联会数据显示，2021年8月乘用车市场零售达到145.3万辆，同比下降14.7%，而且相较2019年8月下降7%，增速偏弱。今年1-8月的零售累计达到1290.0万辆，同比增长17.1%，较1-7月增速下降6个百分点。减速的原因主要是2020年7-8月零售高基数的影响。今年1-8月同比增量188万辆中的新能源车增量就达100万辆，占总增量54% 对1-8月同比增速贡献了9个百分点。</p>\n<p>8月新能源车出口呈现爆发式增长，特斯拉中国出口31,379辆，上汽乘用车的新能源出口4,074辆，比亚迪781辆，爱驰汽车103辆，其他车企新能源车出口也正蓄势待发。2021年比利时成为中国最大汽车出口地。</p>\n<p>8月理想、小鹏、蔚来、合众、零跑等新势力车企销量同比和环比表现总体都很优秀，尤其是哪吒、零跑等二线新势力逐步崛起。主流合资品牌中的南北大众的新能源车批发11,756辆，占据主流合资69%份额。</p>\n<p>8月新能源乘用车市场多元化发力，大集团新能源表现分化，上汽、广汽表现相对较强。厂商批发销量突破万辆的企业有：比亚迪60,858辆、特斯拉中国44,264辆、上汽通用五菱43,783辆、上汽乘用车16,998辆、广汽埃安11,613辆。8月插电混动的比亚迪销量达到30,476辆，环比增长24%，推动平价插电混动增长成新亮点。</p>\n<p>乘联会：随着合资与豪华车企的芯片持续供给不足，加之新能源车的连续火爆，自主品牌的产销也将明显提升，体现了自主品牌供应链自主可控的产业优势。</p>\n<p></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/edb5904d62b10798f760277be625646d","relate_stocks":{"TSLA":"特斯拉","002594":"比亚迪"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199548550","content_text":"乘联会：8月新能源乘用车批发销量达到30.4万辆，同比增长202.3%，环比增长23.7%。1-8月新能源乘用车批发164.3万辆，同比增长222.5%。8月新能源乘用车零售销量达到24.9万辆，同比增长167.5%，环比增12.0%。1-8月新能源车零售147.9万辆，同比增长202.1%。与传统燃油车走势形成强烈差异化的特征，实现对燃油车市场的替代效应，并拉动车市向新能源化转型的步伐。\n乘联会数据显示，2021年8月乘用车市场零售达到145.3万辆，同比下降14.7%，而且相较2019年8月下降7%，增速偏弱。今年1-8月的零售累计达到1290.0万辆，同比增长17.1%，较1-7月增速下降6个百分点。减速的原因主要是2020年7-8月零售高基数的影响。今年1-8月同比增量188万辆中的新能源车增量就达100万辆，占总增量54% 对1-8月同比增速贡献了9个百分点。\n8月新能源车出口呈现爆发式增长，特斯拉中国出口31,379辆，上汽乘用车的新能源出口4,074辆，比亚迪781辆，爱驰汽车103辆，其他车企新能源车出口也正蓄势待发。2021年比利时成为中国最大汽车出口地。\n8月理想、小鹏、蔚来、合众、零跑等新势力车企销量同比和环比表现总体都很优秀，尤其是哪吒、零跑等二线新势力逐步崛起。主流合资品牌中的南北大众的新能源车批发11,756辆，占据主流合资69%份额。\n8月新能源乘用车市场多元化发力，大集团新能源表现分化，上汽、广汽表现相对较强。厂商批发销量突破万辆的企业有：比亚迪60,858辆、特斯拉中国44,264辆、上汽通用五菱43,783辆、上汽乘用车16,998辆、广汽埃安11,613辆。8月插电混动的比亚迪销量达到30,476辆，环比增长24%，推动平价插电混动增长成新亮点。\n乘联会：随着合资与豪华车企的芯片持续供给不足，加之新能源车的连续火爆，自主品牌的产销也将明显提升，体现了自主品牌供应链自主可控的产业优势。","news_type":1},"isVote":1,"tweetType":1,"viewCount":2720,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":894951236,"gmtCreate":1628784658825,"gmtModify":1628784658825,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"华为拷贝部马上加班拷贝[开心]&nbsp;","listText":"华为拷贝部马上加班拷贝[开心]&nbsp;","text":"华为拷贝部马上加班拷贝[开心]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/894951236","repostId":"2158126892","repostType":2,"repost":{"id":"2158126892","pubTimestamp":1628779606,"share":"https://www.laohu8.com/m/news/2158126892?lang=&edition=full","pubTime":"2021-08-12 22:46","market":"us","language":"zh","title":"苹果新专利：把Apple Pencil放在电脑里","url":"https://stock-news.laohu8.com/highlight/detail?id=2158126892","media":"肖瘦人","summary":"8月12日消息，美国专利商标局公布了苹果的一项专利申请，该申请涉及MacBook的新输入系统。苹果这项发明在MacBook键盘上设置了一个带传感器的固定槽，用来固定Apple Pencil，固定槽位于键盘F键一行区域，通过一套“透明系统”，触摸Apple Pencil的不同位置可以激活相应的...","content":"<html><body><div>\n<div itemprop=\"articleBody\">\n<img src=\"https://article-fd.zol-img.com.cn/t_s640x2000/g6/M00/0B/04/ChMkKWEVNWWIOtODAAJJf14wS2sAAStygC_tTcAAkmX073.jpg\"/><div>\n<div><div></div></div>\n</div>\n<p>8月12日消息，美国专利商标局公布了<a href=\"https://laohu8.com/S/AAPL\">苹果</a>的一项专利申请，该申请涉及MacBook的新输入系统。</p><p>苹果这项发明在MacBook键盘上设置了一个带传感器的固定槽，用来固定Apple Pencil，固定槽位于键盘F键一行区域，通过一套“透明系统”，触摸Apple Pencil的不同位置可以激活相应的F键。另外，Apple Pencil可以在固定状态也可以替代部分鼠标的功能。</p><p>这一专利落实到产品上的概率并不会很大，只是代表苹果曾经思考/测试过这些功能，甚至只是奇思妙想。</p><p><span></span><img height=\"1108\" src=\"https://article-fd.zol-img.com.cn/t_s640x2000/g6/M00/0B/04/ChMkKWEVNWWIOtODAAJJf14wS2sAAStygC_tTcAAkmX073.jpg\" width=\"640\"/></p><p>本文属于原创文章，如若转载，请注明来源：苹果新专利：把Apple Pencil放在电脑里https://news.zol.com.cn/774/7745465.html</p><div zpv-events-inview=\"article-cont-bottom-viewport\"></div>\n<div>\n<span itemprop=\"url\">https://news.zol.com.cn/774/7745465.html</span>\n<span itemprop=\"indexUrl\">news.zol.com.cn</span>\n<span itemprop=\"isOriginal\">true</span>\n<span itemprop=\"author\"><a href=\"https://laohu8.com/S/000931\">中关村</a>在线</span>\n<span itemprop=\"isBasedOnUrl\">https://news.zol.com.cn/774/7745465.html</span>\n<span itemprop=\"genre\">report</span>\n<span itemprop=\"wordCount\">406</span>\n<span itemprop=\"description\">8月12日消息，美国专利商标局公布了苹果的一项专利申请，该申请涉及MacBook的新输入系统。苹果这项发明在MacBook键盘上设置了一个带传感器的固定槽，用来固定Apple Pencil，固定槽位于键盘F键一行区域，通过一套“透明系统”，触摸Apple Pencil的不同位置可以激活相应的...</span>\n</div></div>\n</div></body></html>","source":"zol_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>苹果新专利：把Apple Pencil放在电脑里</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n苹果新专利：把Apple Pencil放在电脑里\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-12 22:46 北京时间&nbsp;&nbsp;&nbsp;<a href=http://news.zol.com.cn/774/7745465.html><strong>肖瘦人</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>8月12日消息，美国专利商标局公布了苹果的一项专利申请，该申请涉及MacBook的新输入系统。苹果这项发明在MacBook键盘上设置了一个带传感器的固定槽，用来固定Apple Pencil，固定槽位于键盘F键一行区域，通过一套“透明系统”，触摸Apple Pencil的不同位置可以激活相应的F键。另外，Apple Pencil可以在固定状态也可以替代部分鼠标的功能。这一专利落实到产品上的概率并不会...</p>\n\n<a href=\"http://news.zol.com.cn/774/7745465.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/add5f090cc383f46b0c3a1d49fc9edc5","relate_stocks":{"AAPL":"苹果"},"source_url":"http://news.zol.com.cn/774/7745465.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158126892","content_text":"8月12日消息，美国专利商标局公布了苹果的一项专利申请，该申请涉及MacBook的新输入系统。苹果这项发明在MacBook键盘上设置了一个带传感器的固定槽，用来固定Apple Pencil，固定槽位于键盘F键一行区域，通过一套“透明系统”，触摸Apple Pencil的不同位置可以激活相应的F键。另外，Apple Pencil可以在固定状态也可以替代部分鼠标的功能。这一专利落实到产品上的概率并不会很大，只是代表苹果曾经思考/测试过这些功能，甚至只是奇思妙想。本文属于原创文章，如若转载，请注明来源：苹果新专利：把Apple Pencil放在电脑里https://news.zol.com.cn/774/7745465.html\n\nhttps://news.zol.com.cn/774/7745465.html\nnews.zol.com.cn\ntrue\n中关村在线\nhttps://news.zol.com.cn/774/7745465.html\nreport\n406\n8月12日消息，美国专利商标局公布了苹果的一项专利申请，该申请涉及MacBook的新输入系统。苹果这项发明在MacBook键盘上设置了一个带传感器的固定槽，用来固定Apple Pencil，固定槽位于键盘F键一行区域，通过一套“透明系统”，触摸Apple Pencil的不同位置可以激活相应的...","news_type":1},"isVote":1,"tweetType":1,"viewCount":1591,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":139045016,"gmtCreate":1621578681735,"gmtModify":1621578681735,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"滑而不为，徒有其名","listText":"滑而不为，徒有其名","text":"滑而不为，徒有其名","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/139045016","repostId":"1158351998","repostType":4,"repost":{"id":"1158351998","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1621574806,"share":"https://www.laohu8.com/m/news/1158351998?lang=&edition=full","pubTime":"2021-05-21 13:26","market":"us","language":"zh","title":"华为将扩大与长安汽车的智能汽车合作伙伴关系，以研发芯片","url":"https://stock-news.laohu8.com/highlight/detail?id=1158351998","media":"老虎资讯综合","summary":"5月21日，华为将扩大与汽车制造商长安汽车的智能汽车合作伙伴关系，以研发芯片。据四位知情人士透露，华为正在扩大与重庆长安汽车的智能汽车合作伙伴关系，包括汽车用半导体的设计和开发。两位消息人士称，两家公","content":"<p>5月21日，华为将扩大与汽车制造商长安汽车的智能汽车合作伙伴关系，以研发芯片。</p><p>据四位知情人士透露，华为正在扩大与重庆长安汽车的智能汽车合作伙伴关系，包括汽车用半导体的设计和开发。两位消息人士称，两家公司在去年11月公布了智能汽车合作计划，过去几个月一直在芯片方面非正式合作。另一位消息人士称，他们可能很快就会成立一家芯片开发合资企业。</p><p>对此长安汽车有关部门回应：我们(和华为)主要合作的是全新平台的开发，以及品牌的合作。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>华为将扩大与长安汽车的智能汽车合作伙伴关系，以研发芯片</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n华为将扩大与长安汽车的智能汽车合作伙伴关系，以研发芯片\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-05-21 13:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>5月21日，华为将扩大与汽车制造商长安汽车的智能汽车合作伙伴关系，以研发芯片。</p><p>据四位知情人士透露，华为正在扩大与重庆长安汽车的智能汽车合作伙伴关系，包括汽车用半导体的设计和开发。两位消息人士称，两家公司在去年11月公布了智能汽车合作计划，过去几个月一直在芯片方面非正式合作。另一位消息人士称，他们可能很快就会成立一家芯片开发合资企业。</p><p>对此长安汽车有关部门回应：我们(和华为)主要合作的是全新平台的开发，以及品牌的合作。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/7f0607d088fd08637f4d6d330897aafb","relate_stocks":{},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158351998","content_text":"5月21日，华为将扩大与汽车制造商长安汽车的智能汽车合作伙伴关系，以研发芯片。据四位知情人士透露，华为正在扩大与重庆长安汽车的智能汽车合作伙伴关系，包括汽车用半导体的设计和开发。两位消息人士称，两家公司在去年11月公布了智能汽车合作计划，过去几个月一直在芯片方面非正式合作。另一位消息人士称，他们可能很快就会成立一家芯片开发合资企业。对此长安汽车有关部门回应：我们(和华为)主要合作的是全新平台的开发，以及品牌的合作。","news_type":1},"isVote":1,"tweetType":1,"viewCount":2107,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":105610942,"gmtCreate":1620297042686,"gmtModify":1620297042686,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"蟑狼要被气哭，销量怎么还这么好😄","listText":"蟑狼要被气哭，销量怎么还这么好😄","text":"蟑狼要被气哭，销量怎么还这么好😄","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/105610942","repostId":"1199027482","repostType":2,"repost":{"id":"1199027482","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1620296747,"share":"https://www.laohu8.com/m/news/1199027482?lang=&edition=full","pubTime":"2021-05-06 18:25","market":"us","language":"zh","title":"外媒：特斯拉需求异常强劲，第二季度产能已经售罄","url":"https://stock-news.laohu8.com/highlight/detail?id=1199027482","media":"老虎资讯综合","summary":"据ELECTREK：目前$特斯拉(TSLA)$的汽车需求异常强劲，第二季度产能已经售罄。\n\n预计特斯拉本季度的产能将略高于上季度180338辆的创纪录产量。\n\n特斯拉盘前快速上扬，截至发稿涨超2%。","content":"<p>据ELECTREK：目前<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>的汽车需求异常强劲，第二季度产能已经售罄。</p><p>预计特斯拉本季度的产能将略高于上季度180338辆的创纪录产量。</p><p>特斯拉盘前快速上扬，截至发稿涨超2%。</p><p><img src=\"https://static.tigerbbs.com/4e50a2878cdaa5cadb86565dfadbdd2a\" tg-width=\"600\" tg-height=\"373\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>外媒：特斯拉需求异常强劲，第二季度产能已经售罄</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n外媒：特斯拉需求异常强劲，第二季度产能已经售罄\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-05-06 18:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>据ELECTREK：目前<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>的汽车需求异常强劲，第二季度产能已经售罄。</p><p>预计特斯拉本季度的产能将略高于上季度180338辆的创纪录产量。</p><p>特斯拉盘前快速上扬，截至发稿涨超2%。</p><p><img src=\"https://static.tigerbbs.com/4e50a2878cdaa5cadb86565dfadbdd2a\" tg-width=\"600\" tg-height=\"373\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/2ba18e4c173130d8ec828f5035d30189","relate_stocks":{"TSLA":"特斯拉"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199027482","content_text":"据ELECTREK：目前特斯拉的汽车需求异常强劲，第二季度产能已经售罄。预计特斯拉本季度的产能将略高于上季度180338辆的创纪录产量。特斯拉盘前快速上扬，截至发稿涨超2%。","news_type":1},"isVote":1,"tweetType":1,"viewCount":2132,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":108711974,"gmtCreate":1620053993698,"gmtModify":1620053993698,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VAL\">$华仕伯(VAL)$</a>终于重组成功了！有票的兄弟是不是被清零了？","listText":"<a href=\"https://laohu8.com/S/VAL\">$华仕伯(VAL)$</a>终于重组成功了！有票的兄弟是不是被清零了？","text":"$华仕伯(VAL)$终于重组成功了！有票的兄弟是不是被清零了？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/108711974","isVote":1,"tweetType":1,"viewCount":4872,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3548566245371949","authorId":"3548566245371949","name":"wzxmypwj","avatar":"https://static.tigerbbs.com/f749249dd00b0c60c84b12290ccec6a4","crmLevel":2,"crmLevelSwitch":0,"idStr":"3548566245371949","authorIdStr":"3548566245371949"},"content":"在粉单，但是粉单也退市无法交易了，只能等消息","text":"在粉单，但是粉单也退市无法交易了，只能等消息","html":"在粉单，但是粉单也退市无法交易了，只能等消息"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":389641008,"gmtCreate":1612772265004,"gmtModify":1703764779808,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"格局限制，也只能做国内的B站","listText":"格局限制，也只能做国内的B站","text":"格局限制，也只能做国内的B站","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/389641008","repostId":"2109746767","repostType":2,"isVote":1,"tweetType":1,"viewCount":2145,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":331438031,"gmtCreate":1609746419023,"gmtModify":1703740159532,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"台积电2021年产能铺满，没有多余产能了","listText":"台积电2021年产能铺满，没有多余产能了","text":"台积电2021年产能铺满，没有多余产能了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/331438031","repostId":"2100637027","repostType":2,"repost":{"id":"2100637027","pubTimestamp":1609560970,"share":"https://www.laohu8.com/m/news/2100637027?lang=&edition=full","pubTime":"2021-01-02 12:16","market":"us","language":"zh","title":"ASML传来坏消息！张忠谋：国产光刻机迎来磨难，台积电首当其冲","url":"https://stock-news.laohu8.com/highlight/detail?id=2100637027","media":"星新看世界","summary":"任正非先生此前表示，国内的基础制造无法生产麒麟芯片，这也揭示了华为当前的尴尬状况，同时也彰显了光刻机这项技术的重要性。目前可以制造高级芯片的光刻机只能由荷兰的ASML集团生产。可以说，如果没有ASML的EUV光刻机，台积电和三星都将无法生产高端芯片。所以才会说ASML集团传来的是一个坏消息，国内的光刻机将迎来磨难，而台积电无疑是首当其冲的。","content":"<html><body><article><p>美国针对我们国家的芯片禁令暴露了我们国家很多的问题，其实华为已经是拥有了设计世界顶尖芯片的能力，但是没有办法，制造芯片最重要的光刻机技术掌握在西方国家的手中，所以即便华为拥有设计顶级芯片的能力，但是仍然受制于光刻机技术的缺失。</p><img src=\"https://fid-75186.picgzc.qpic.cn/20210102152423449v1734glim02bisv\"/><p>主要还是因为我们国家在光刻机技术领域发展的比较晚，所以才会受到美国的掣肘。任正非先生此前表示，国内的基础制造无法生产麒麟芯片，这也揭示了华为当前的尴尬状况，同时也彰显了光刻机这项技术的重要性。</p><img src=\"https://fid-75186.picgzc.qpic.cn/20210102152428518v173kcq35y0vown\"/><p>ASML传来坏消息！张忠谋：国产光刻机迎来磨难，<a href=\"https://laohu8.com/S/TSM\">台积电</a>首当其冲！目前可以制造高级芯片的光刻机只能由荷兰的ASML集团生产。ASML集团在光刻机领域有着绝对的话语权，然而，即便如此，因为ASML集团很多的核心技术都是美国支撑着，所以也只能听从美国的指令。</p><img src=\"https://fid-75186.picgzc.qpic.cn/20210102152430047v173imsbrwedl05\"/><p>可以说，如果没有ASML的EUV光刻机，台积电和<a href=\"https://laohu8.com/S/SMSN.UK\">三星</a>都将无法生产高端芯片。可是，最近又有一个不好的消息，ASML开发的NA EUV光刻机已经完成了基本设计，并很快就能够实现商业化，这个新光刻机将能够用于生产2nm甚至1nm工艺芯片。</p><img src=\"https://fid-75186.picgzc.qpic.cn/20210102152439687v173lfz7iszkq3c\"/><p>可是，国产光刻机才刚刚勉强突破到7nm的层次，如今ASML集团的光刻机技术就再次突破，那么我们国家想要在光刻机技术上面追赶上来，难度再次增大了。此外，一台NA EUV光刻机的售价高达4.5亿美元，台积电是ASML集团最大的客户，但是台积电的实力不太能够吃得消这么昂贵的设备。</p><img src=\"https://inews.gtimg.com/newsapp_bt/0/12990156537/1000\"/><p>毕竟台积电刚刚失去了华为这个大客户，再加上<a href=\"https://laohu8.com/S/QCOM\">高通</a>和<a href=\"https://laohu8.com/S/INTC\">英特尔</a>的订单又被三星抢走了，台积电的利润下降的同时，设备的成本还增加了，这令台积电陷入了一个两难境地。而台积电的对手三星财大气粗，反而可以大肆购买现金设备，从而不断抢占台积电的市场。所以才会说ASML集团传来的是一个坏消息，国内的光刻机将迎来磨难，而台积电无疑是首当其冲的。</p></article></body></html>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ASML传来坏消息！张忠谋：国产光刻机迎来磨难，台积电首当其冲</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nASML传来坏消息！张忠谋：国产光刻机迎来磨难，台积电首当其冲\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-01-02 12:16 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021010215245677d80fde&s=b><strong>星新看世界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>美国针对我们国家的芯片禁令暴露了我们国家很多的问题，其实华为已经是拥有了设计世界顶尖芯片的能力，但是没有办法，制造芯片最重要的光刻机技术掌握在西方国家的手中，所以即便华为拥有设计顶级芯片的能力，但是仍然受制于光刻机技术的缺失。主要还是因为我们国家在光刻机技术领域发展的比较晚，所以才会受到美国的掣肘。任正非先生此前表示，国内的基础制造无法生产麒麟芯片，这也揭示了华为当前的尴尬状况，同时也彰显了光刻机...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021010215245677d80fde&s=b\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/975836d8c6eb511241583dccb0d387f2","relate_stocks":{"EWT":"台湾ETF-iShares MSCI","TSM":"台积电","03145":"华夏亚洲高息股"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021010215245677d80fde&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2100637027","content_text":"美国针对我们国家的芯片禁令暴露了我们国家很多的问题，其实华为已经是拥有了设计世界顶尖芯片的能力，但是没有办法，制造芯片最重要的光刻机技术掌握在西方国家的手中，所以即便华为拥有设计顶级芯片的能力，但是仍然受制于光刻机技术的缺失。主要还是因为我们国家在光刻机技术领域发展的比较晚，所以才会受到美国的掣肘。任正非先生此前表示，国内的基础制造无法生产麒麟芯片，这也揭示了华为当前的尴尬状况，同时也彰显了光刻机这项技术的重要性。ASML传来坏消息！张忠谋：国产光刻机迎来磨难，台积电首当其冲！目前可以制造高级芯片的光刻机只能由荷兰的ASML集团生产。ASML集团在光刻机领域有着绝对的话语权，然而，即便如此，因为ASML集团很多的核心技术都是美国支撑着，所以也只能听从美国的指令。可以说，如果没有ASML的EUV光刻机，台积电和三星都将无法生产高端芯片。可是，最近又有一个不好的消息，ASML开发的NA EUV光刻机已经完成了基本设计，并很快就能够实现商业化，这个新光刻机将能够用于生产2nm甚至1nm工艺芯片。可是，国产光刻机才刚刚勉强突破到7nm的层次，如今ASML集团的光刻机技术就再次突破，那么我们国家想要在光刻机技术上面追赶上来，难度再次增大了。此外，一台NA EUV光刻机的售价高达4.5亿美元，台积电是ASML集团最大的客户，但是台积电的实力不太能够吃得消这么昂贵的设备。毕竟台积电刚刚失去了华为这个大客户，再加上高通和英特尔的订单又被三星抢走了，台积电的利润下降的同时，设备的成本还增加了，这令台积电陷入了一个两难境地。而台积电的对手三星财大气粗，反而可以大肆购买现金设备，从而不断抢占台积电的市场。所以才会说ASML集团传来的是一个坏消息，国内的光刻机将迎来磨难，而台积电无疑是首当其冲的。","news_type":1},"isVote":1,"tweetType":1,"viewCount":3248,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":396365893,"gmtCreate":1607045792812,"gmtModify":1703846098321,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/00282\">$壹传媒(00282)$</a>又涨了[笑哭]&nbsp;","listText":"<a href=\"https://laohu8.com/S/00282\">$壹传媒(00282)$</a>又涨了[笑哭]&nbsp;","text":"$壹传媒(00282)$又涨了[笑哭]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/396365893","isVote":1,"tweetType":1,"viewCount":2358,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":303562759,"gmtCreate":1603201566171,"gmtModify":1703829046519,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VAL\">$华仕伯(VAL)$</a>怎么从退市变成停牌了？","listText":"<a href=\"https://laohu8.com/S/VAL\">$华仕伯(VAL)$</a>怎么从退市变成停牌了？","text":"$华仕伯(VAL)$怎么从退市变成停牌了？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/303562759","isVote":1,"tweetType":1,"viewCount":2318,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":972632481,"gmtCreate":1600199728243,"gmtModify":1703820725001,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/972632481","repostId":"2066210025","repostType":2,"repost":{"id":"2066210025","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1599586620,"share":"https://www.laohu8.com/m/news/2066210025?lang=&edition=full","pubTime":"2020-09-09 01:37","market":"us","language":"en","title":"There are seven coronavirus vaccine candidates being tested in the U.S. -- here's where they stand","url":"https://stock-news.laohu8.com/highlight/detail?id=2066210025","media":"Dow Jones","summary":"MW UPDATE: There are seven coronavirus vaccine candidates being tested in the U.S. -- here's where t","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW UPDATE: There are seven coronavirus vaccine candidates being tested in the U.S. -- here's where they stand\n</p>\n<p>\n  By Jaimy Lee \n</p>\n<p>\n  At least three of the still investigational vaccines have moved into Phase 3 clinical trials \n</p>\n<p>\n  The race to develop a safe and effective COVID-19 vaccine is well under way, setting the stage to bring to market the fastest vaccine in history. \n</p>\n<p>\n  There are dozens of coronavirus vaccines in development, primarily in the preclinical phase when they are tested on animals. In the U.S., there are seven vaccine candidates that have moved into clinical trials with human participants, including three that have moved into the crucial Phase 3 development phase. \n</p>\n<p>\n  The first and second phases of clinical studies are primarily conducted to test for safety, while the third and final stage is used to determine whether the vaccines are efficacious and can prevent infection among participants. At that point, the vaccine makers will decide when to pursue an emergency use authorization from the Food and Drug Administration and/or a full approval. The majority of the vaccines in development have received funding from the U.S. government, either to help support clinical development or pay for manufacturing and distribution of the vaccines as part of the Trump administration's Operation Warp Speed program. \n</p>\n<p>\n  MarketWatch will update this tally as the vaccines move through development. \n</p>\n<p>\n  Vaccines that have entered Phase 3 trials in the U.S. (cited in alphabetical order, by company name): \n</p>\n<p>\n  AstraZeneca, in partnership with the University of Oxford \n</p>\n<p>\n  Year-to-date stock performance:(AZN.LN) (AZN.LN) Up 7.8% \n</p>\n<p>\n  Name: AZD1222 \n</p>\n<p>\n  Type: Vector-based \n</p>\n<p>\n  Phase 1/2: Data from the Phase 1/2 trial, which is being conducted in the U.K., was published July 20 in The Lancet  neutralizing antibody responses in 91% of 35 patients when using <a href=\"https://laohu8.com/S/AONE.U\">one</a> test and 100% of 35 patients when using a different test. \n</p>\n<p>\n  Phase 3: This trial, which will be held in the U.S., is expected to enroll up to 30,000 participants. (Late-stage studies are also being conducted in Brazil, and South Africa, and the U.K.) Data is expected by the end of the year. \n</p>\n<p>\n  Clinical development and manufacturing funding from the U.S. government: up to $1.2 billion \n</p>\n<p>\n  U.S. dose promise: 300 million doses \n</p>\n<p>\n  Dosing: 2 doses \n</p>\n<p>\n  BioNTech  and Pfizer Inc. \n</p>\n<p>\n  Year-to-date stock performances: BioNTech<a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a>, up 75.0%; Pfizer<a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a>, down 8.3%. \n</p>\n<p>\n  Name: BNT162b2 \n</p>\n<p>\n  Type: mRNA \n</p>\n<p>\n  Phase 1: The companies published preliminary data on July 1 for BNT162b1 as a preprint  was published on Aug. 28 for BNT162b2 that found this candidate produced similar levels of antibodies but participants reported fewer reactions. \n</p>\n<p>\n    This trial is expected to focus on BNT162b2. It is expected to enroll up to 30,000 participants in Argentina, Brazil, and the U.S. \n</p>\n<p>\n  Manufacturing funding from the U.S. government: $1.95 billion \n</p>\n<p>\n  U.S. dose promise: 100 million doses, with option to buy up to 500 million more doses \n</p>\n<p>\n  Dosing: 2 doses \n</p>\n<p>\n  Moderna Inc. \n</p>\n<p>\n  Year-to-date stock performance:<a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> Up 187.8% \n</p>\n<p>\n  Name: mRNA-1273 \n</p>\n<p>\n  Type: mRNA \n</p>\n<p>\n  Phase 1 . Moderna's vaccine candidate elicited neutralizing antibodies in all 45 participants in this trial, which was conducted in the U.S. in partnership with the National Institute of Allergy and Infectious Diseases. \n</p>\n<p>\n  Phase 2a : This study closed enrollment of 600 participants on July 8. This trial is also focused on the U.S. \n</p>\n<p>\n  Phase 3 : This study is expected to complete enrollment of up to 30,000 people sometime in September. \n</p>\n<p>\n  R&amp;D funding from BARDA: $955 million \n</p>\n<p>\n  Supply funding from the U.S. government: Up to $1.525 billion \n</p>\n<p>\n  U.S. dose promise: 100 million, with option to acquire up 400 million additional doses \n</p>\n<p>\n  Dosing: 2 doses \n</p>\n<p>\n  Vaccines that have entered Phase 1 and 2 trials in the U.S. (cited in alphabetical order, by company name): \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/INO\">Inovio Pharmaceuticals Inc</a>. \n</p>\n<p>\n  Year-to-date stock performance:(INO)up 191.2% \n</p>\n<p>\n  Name: INO-4800 \n</p>\n<p>\n  Type: DNA \n</p>\n<p>\n  Phase 1  on June; it has not yet shared the full data but has submitted the results for publication in a peer-reviewed medical journal. The trial is being conducted in the U.S. \n</p>\n<p>\n  Phase 2/3: Inovio said Sept. 8 it plans to launch this phase of the study in September, if it is given the go-ahead by the FDA. \n</p>\n<p>\n  U.S. government funding: It received $71 million  from the Department of Defense to make and buy the devices that will be used to dispense the company's vaccine if it is authorized or approved. \n</p>\n<p>\n  Johnson &amp; Johnson \n</p>\n<p>\n  Year-to-date stock performance:<a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> Up 1.2% \n</p>\n<p>\n  Name: Ad26. COV2. S \n</p>\n<p>\n  Type: Vector-based \n</p>\n<p>\n  Phase 1/2a  in the second half of July, with a goal of enrolling 1,045 adults in Belgium and the U.S. \n</p>\n<p>\n  Phase 3: It plans to launch this trial in September. \n</p>\n<p>\n  R&amp;D funding from BARDA: $456 million \n</p>\n<p>\n  U.S. government funding for manufacturing and delivery:More than $1 billion  \n</p>\n<p>\n  U.S. dose promise: 100 million doses, with option to buy up to 200 million additional doses \n</p>\n<p>\n  Novavax Inc. \n</p>\n<p>\n  Year-to-date stock performance:<a href=\"https://laohu8.com/S/NVAX\">$(NVAX)$</a> Up 2,167.6% \n</p>\n<p>\n  Name: NVX-CoV2373 \n</p>\n<p>\n  Type: Protein subunit \n</p>\n<p>\n  Phase 1: . \n</p>\n<p>\n  Phase 1/2: The second phase of the Phase 1/2 trial started in August and will be conducted in Australia and the U.S. \n</p>\n<p>\n  Phase 3: TBD \n</p>\n<p>\n  Clinical development and manufacturing funding from the U.S. government:$1.6 billion  \n</p>\n<p>\n  U.S. dose promise: 100 million doses \n</p>\n<pre><table><tbody><tr><td></td><td>Sanofi</td><td>in combination with GlaxoSmithKline's (TICKER:GSK) (TICKER:UK:GSK)</td><td>adjuvant technology </td></tr></tbody></table></pre>\n<p>\n  Companies: \n</p>\n<p>\n  Year-to-date stock performance: Sanofi (SAN.FR)(SAN.FR) Up 0.6%. \n</p>\n<p>\n  Name: TBD \n</p>\n<p>\n  Type: Protein-based \n</p>\n<p>\n  Phase 1/2 study: The trial was initiated Sept. 3 , with a goal of enrolling 440 adults in the U.S. Results are expected in December. \n</p>\n<p>\n  Phase 3: This study is expected to launch by the \"end of 2020.\" \n</p>\n<p>\n  Clinical development and manufacturing funding from the U.S. government: Up to $2.1 billion \n</p>\n<p>\n  U.S. dose promise: Up to 100 million doses, with option to buy up to 500 million doses \n</p>\n<pre><table><tbody><tr><td>Sources: Company websites, federal data, the World Health Organization, RBC Capital Markets </td></tr></tbody></table></pre>\n<p>\n  -Jaimy Lee; 415-439-6400; AskNewswires@dowjones.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 08, 2020 13:37 ET (17:37 GMT)\n</p>\n<p>\n  Copyright (c) 2020 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>There are seven coronavirus vaccine candidates being tested in the U.S. -- here's where they stand</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThere are seven coronavirus vaccine candidates being tested in the U.S. -- here's where they stand\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2020-09-09 01:37</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW UPDATE: There are seven coronavirus vaccine candidates being tested in the U.S. -- here's where they stand\n</p>\n<p>\n  By Jaimy Lee \n</p>\n<p>\n  At least three of the still investigational vaccines have moved into Phase 3 clinical trials \n</p>\n<p>\n  The race to develop a safe and effective COVID-19 vaccine is well under way, setting the stage to bring to market the fastest vaccine in history. \n</p>\n<p>\n  There are dozens of coronavirus vaccines in development, primarily in the preclinical phase when they are tested on animals. In the U.S., there are seven vaccine candidates that have moved into clinical trials with human participants, including three that have moved into the crucial Phase 3 development phase. \n</p>\n<p>\n  The first and second phases of clinical studies are primarily conducted to test for safety, while the third and final stage is used to determine whether the vaccines are efficacious and can prevent infection among participants. At that point, the vaccine makers will decide when to pursue an emergency use authorization from the Food and Drug Administration and/or a full approval. The majority of the vaccines in development have received funding from the U.S. government, either to help support clinical development or pay for manufacturing and distribution of the vaccines as part of the Trump administration's Operation Warp Speed program. \n</p>\n<p>\n  MarketWatch will update this tally as the vaccines move through development. \n</p>\n<p>\n  Vaccines that have entered Phase 3 trials in the U.S. (cited in alphabetical order, by company name): \n</p>\n<p>\n  AstraZeneca, in partnership with the University of Oxford \n</p>\n<p>\n  Year-to-date stock performance:(AZN.LN) (AZN.LN) Up 7.8% \n</p>\n<p>\n  Name: AZD1222 \n</p>\n<p>\n  Type: Vector-based \n</p>\n<p>\n  Phase 1/2: Data from the Phase 1/2 trial, which is being conducted in the U.K., was published July 20 in The Lancet  neutralizing antibody responses in 91% of 35 patients when using <a href=\"https://laohu8.com/S/AONE.U\">one</a> test and 100% of 35 patients when using a different test. \n</p>\n<p>\n  Phase 3: This trial, which will be held in the U.S., is expected to enroll up to 30,000 participants. (Late-stage studies are also being conducted in Brazil, and South Africa, and the U.K.) Data is expected by the end of the year. \n</p>\n<p>\n  Clinical development and manufacturing funding from the U.S. government: up to $1.2 billion \n</p>\n<p>\n  U.S. dose promise: 300 million doses \n</p>\n<p>\n  Dosing: 2 doses \n</p>\n<p>\n  BioNTech  and Pfizer Inc. \n</p>\n<p>\n  Year-to-date stock performances: BioNTech<a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a>, up 75.0%; Pfizer<a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a>, down 8.3%. \n</p>\n<p>\n  Name: BNT162b2 \n</p>\n<p>\n  Type: mRNA \n</p>\n<p>\n  Phase 1: The companies published preliminary data on July 1 for BNT162b1 as a preprint  was published on Aug. 28 for BNT162b2 that found this candidate produced similar levels of antibodies but participants reported fewer reactions. \n</p>\n<p>\n    This trial is expected to focus on BNT162b2. It is expected to enroll up to 30,000 participants in Argentina, Brazil, and the U.S. \n</p>\n<p>\n  Manufacturing funding from the U.S. government: $1.95 billion \n</p>\n<p>\n  U.S. dose promise: 100 million doses, with option to buy up to 500 million more doses \n</p>\n<p>\n  Dosing: 2 doses \n</p>\n<p>\n  Moderna Inc. \n</p>\n<p>\n  Year-to-date stock performance:<a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> Up 187.8% \n</p>\n<p>\n  Name: mRNA-1273 \n</p>\n<p>\n  Type: mRNA \n</p>\n<p>\n  Phase 1 . Moderna's vaccine candidate elicited neutralizing antibodies in all 45 participants in this trial, which was conducted in the U.S. in partnership with the National Institute of Allergy and Infectious Diseases. \n</p>\n<p>\n  Phase 2a : This study closed enrollment of 600 participants on July 8. This trial is also focused on the U.S. \n</p>\n<p>\n  Phase 3 : This study is expected to complete enrollment of up to 30,000 people sometime in September. \n</p>\n<p>\n  R&amp;D funding from BARDA: $955 million \n</p>\n<p>\n  Supply funding from the U.S. government: Up to $1.525 billion \n</p>\n<p>\n  U.S. dose promise: 100 million, with option to acquire up 400 million additional doses \n</p>\n<p>\n  Dosing: 2 doses \n</p>\n<p>\n  Vaccines that have entered Phase 1 and 2 trials in the U.S. (cited in alphabetical order, by company name): \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/INO\">Inovio Pharmaceuticals Inc</a>. \n</p>\n<p>\n  Year-to-date stock performance:(INO)up 191.2% \n</p>\n<p>\n  Name: INO-4800 \n</p>\n<p>\n  Type: DNA \n</p>\n<p>\n  Phase 1  on June; it has not yet shared the full data but has submitted the results for publication in a peer-reviewed medical journal. The trial is being conducted in the U.S. \n</p>\n<p>\n  Phase 2/3: Inovio said Sept. 8 it plans to launch this phase of the study in September, if it is given the go-ahead by the FDA. \n</p>\n<p>\n  U.S. government funding: It received $71 million  from the Department of Defense to make and buy the devices that will be used to dispense the company's vaccine if it is authorized or approved. \n</p>\n<p>\n  Johnson &amp; Johnson \n</p>\n<p>\n  Year-to-date stock performance:<a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> Up 1.2% \n</p>\n<p>\n  Name: Ad26. COV2. S \n</p>\n<p>\n  Type: Vector-based \n</p>\n<p>\n  Phase 1/2a  in the second half of July, with a goal of enrolling 1,045 adults in Belgium and the U.S. \n</p>\n<p>\n  Phase 3: It plans to launch this trial in September. \n</p>\n<p>\n  R&amp;D funding from BARDA: $456 million \n</p>\n<p>\n  U.S. government funding for manufacturing and delivery:More than $1 billion  \n</p>\n<p>\n  U.S. dose promise: 100 million doses, with option to buy up to 200 million additional doses \n</p>\n<p>\n  Novavax Inc. \n</p>\n<p>\n  Year-to-date stock performance:<a href=\"https://laohu8.com/S/NVAX\">$(NVAX)$</a> Up 2,167.6% \n</p>\n<p>\n  Name: NVX-CoV2373 \n</p>\n<p>\n  Type: Protein subunit \n</p>\n<p>\n  Phase 1: . \n</p>\n<p>\n  Phase 1/2: The second phase of the Phase 1/2 trial started in August and will be conducted in Australia and the U.S. \n</p>\n<p>\n  Phase 3: TBD \n</p>\n<p>\n  Clinical development and manufacturing funding from the U.S. government:$1.6 billion  \n</p>\n<p>\n  U.S. dose promise: 100 million doses \n</p>\n<pre><table><tbody><tr><td></td><td>Sanofi</td><td>in combination with GlaxoSmithKline's (TICKER:GSK) (TICKER:UK:GSK)</td><td>adjuvant technology </td></tr></tbody></table></pre>\n<p>\n  Companies: \n</p>\n<p>\n  Year-to-date stock performance: Sanofi (SAN.FR)(SAN.FR) Up 0.6%. \n</p>\n<p>\n  Name: TBD \n</p>\n<p>\n  Type: Protein-based \n</p>\n<p>\n  Phase 1/2 study: The trial was initiated Sept. 3 , with a goal of enrolling 440 adults in the U.S. Results are expected in December. \n</p>\n<p>\n  Phase 3: This study is expected to launch by the \"end of 2020.\" \n</p>\n<p>\n  Clinical development and manufacturing funding from the U.S. government: Up to $2.1 billion \n</p>\n<p>\n  U.S. dose promise: Up to 100 million doses, with option to buy up to 500 million doses \n</p>\n<pre><table><tbody><tr><td>Sources: Company websites, federal data, the World Health Organization, RBC Capital Markets </td></tr></tbody></table></pre>\n<p>\n  -Jaimy Lee; 415-439-6400; AskNewswires@dowjones.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 08, 2020 13:37 ET (17:37 GMT)\n</p>\n<p>\n  Copyright (c) 2020 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"INO":"伊诺维奥制药","JNJ":"强生","MRNA":"Moderna, Inc.","AZN":"阿斯利康","SNY":"赛诺菲安万特","PFE":"辉瑞","NVAX":"诺瓦瓦克斯医药","GSK.UK":"葛兰素史克","GSK":"葛兰素史克","BNTX":"BioNTech SE"},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2066210025","content_text":"MW UPDATE: There are seven coronavirus vaccine candidates being tested in the U.S. -- here's where they stand\n\n\n  By Jaimy Lee \n\n\n  At least three of the still investigational vaccines have moved into Phase 3 clinical trials \n\n\n  The race to develop a safe and effective COVID-19 vaccine is well under way, setting the stage to bring to market the fastest vaccine in history. \n\n\n  There are dozens of coronavirus vaccines in development, primarily in the preclinical phase when they are tested on animals. In the U.S., there are seven vaccine candidates that have moved into clinical trials with human participants, including three that have moved into the crucial Phase 3 development phase. \n\n\n  The first and second phases of clinical studies are primarily conducted to test for safety, while the third and final stage is used to determine whether the vaccines are efficacious and can prevent infection among participants. At that point, the vaccine makers will decide when to pursue an emergency use authorization from the Food and Drug Administration and/or a full approval. The majority of the vaccines in development have received funding from the U.S. government, either to help support clinical development or pay for manufacturing and distribution of the vaccines as part of the Trump administration's Operation Warp Speed program. \n\n\n  MarketWatch will update this tally as the vaccines move through development. \n\n\n  Vaccines that have entered Phase 3 trials in the U.S. (cited in alphabetical order, by company name): \n\n\n  AstraZeneca, in partnership with the University of Oxford \n\n\n  Year-to-date stock performance:(AZN.LN) (AZN.LN) Up 7.8% \n\n\n  Name: AZD1222 \n\n\n  Type: Vector-based \n\n\n  Phase 1/2: Data from the Phase 1/2 trial, which is being conducted in the U.K., was published July 20 in The Lancet  neutralizing antibody responses in 91% of 35 patients when using one test and 100% of 35 patients when using a different test. \n\n\n  Phase 3: This trial, which will be held in the U.S., is expected to enroll up to 30,000 participants. (Late-stage studies are also being conducted in Brazil, and South Africa, and the U.K.) Data is expected by the end of the year. \n\n\n  Clinical development and manufacturing funding from the U.S. government: up to $1.2 billion \n\n\n  U.S. dose promise: 300 million doses \n\n\n  Dosing: 2 doses \n\n\n  BioNTech  and Pfizer Inc. \n\n\n  Year-to-date stock performances: BioNTech$(BNTX)$, up 75.0%; Pfizer$(PFE)$, down 8.3%. \n\n\n  Name: BNT162b2 \n\n\n  Type: mRNA \n\n\n  Phase 1: The companies published preliminary data on July 1 for BNT162b1 as a preprint  was published on Aug. 28 for BNT162b2 that found this candidate produced similar levels of antibodies but participants reported fewer reactions. \n\n\n    This trial is expected to focus on BNT162b2. It is expected to enroll up to 30,000 participants in Argentina, Brazil, and the U.S. \n\n\n  Manufacturing funding from the U.S. government: $1.95 billion \n\n\n  U.S. dose promise: 100 million doses, with option to buy up to 500 million more doses \n\n\n  Dosing: 2 doses \n\n\n  Moderna Inc. \n\n\n  Year-to-date stock performance:$(MRNA)$ Up 187.8% \n\n\n  Name: mRNA-1273 \n\n\n  Type: mRNA \n\n\n  Phase 1 . Moderna's vaccine candidate elicited neutralizing antibodies in all 45 participants in this trial, which was conducted in the U.S. in partnership with the National Institute of Allergy and Infectious Diseases. \n\n\n  Phase 2a : This study closed enrollment of 600 participants on July 8. This trial is also focused on the U.S. \n\n\n  Phase 3 : This study is expected to complete enrollment of up to 30,000 people sometime in September. \n\n\n  R&D funding from BARDA: $955 million \n\n\n  Supply funding from the U.S. government: Up to $1.525 billion \n\n\n  U.S. dose promise: 100 million, with option to acquire up 400 million additional doses \n\n\n  Dosing: 2 doses \n\n\n  Vaccines that have entered Phase 1 and 2 trials in the U.S. (cited in alphabetical order, by company name): \n\n\nInovio Pharmaceuticals Inc. \n\n\n  Year-to-date stock performance:(INO)up 191.2% \n\n\n  Name: INO-4800 \n\n\n  Type: DNA \n\n\n  Phase 1  on June; it has not yet shared the full data but has submitted the results for publication in a peer-reviewed medical journal. The trial is being conducted in the U.S. \n\n\n  Phase 2/3: Inovio said Sept. 8 it plans to launch this phase of the study in September, if it is given the go-ahead by the FDA. \n\n\n  U.S. government funding: It received $71 million  from the Department of Defense to make and buy the devices that will be used to dispense the company's vaccine if it is authorized or approved. \n\n\n  Johnson & Johnson \n\n\n  Year-to-date stock performance:$(JNJ)$ Up 1.2% \n\n\n  Name: Ad26. COV2. S \n\n\n  Type: Vector-based \n\n\n  Phase 1/2a  in the second half of July, with a goal of enrolling 1,045 adults in Belgium and the U.S. \n\n\n  Phase 3: It plans to launch this trial in September. \n\n\n  R&D funding from BARDA: $456 million \n\n\n  U.S. government funding for manufacturing and delivery:More than $1 billion  \n\n\n  U.S. dose promise: 100 million doses, with option to buy up to 200 million additional doses \n\n\n  Novavax Inc. \n\n\n  Year-to-date stock performance:$(NVAX)$ Up 2,167.6% \n\n\n  Name: NVX-CoV2373 \n\n\n  Type: Protein subunit \n\n\n  Phase 1: . \n\n\n  Phase 1/2: The second phase of the Phase 1/2 trial started in August and will be conducted in Australia and the U.S. \n\n\n  Phase 3: TBD \n\n\n  Clinical development and manufacturing funding from the U.S. government:$1.6 billion  \n\n\n  U.S. dose promise: 100 million doses \n\nSanofiin combination with GlaxoSmithKline's (TICKER:GSK) (TICKER:UK:GSK)adjuvant technology \n\n  Companies: \n\n\n  Year-to-date stock performance: Sanofi (SAN.FR)(SAN.FR) Up 0.6%. \n\n\n  Name: TBD \n\n\n  Type: Protein-based \n\n\n  Phase 1/2 study: The trial was initiated Sept. 3 , with a goal of enrolling 440 adults in the U.S. Results are expected in December. \n\n\n  Phase 3: This study is expected to launch by the \"end of 2020.\" \n\n\n  Clinical development and manufacturing funding from the U.S. government: Up to $2.1 billion \n\n\n  U.S. dose promise: Up to 100 million doses, with option to buy up to 500 million doses \n\nSources: Company websites, federal data, the World Health Organization, RBC Capital Markets \n\n  -Jaimy Lee; 415-439-6400; AskNewswires@dowjones.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 08, 2020 13:37 ET (17:37 GMT)\n\n\n  Copyright (c) 2020 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1231,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":978038598,"gmtCreate":1599059790014,"gmtModify":1704221353581,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/WLL\">$Whiting Petroleum Corp(WLL)$</a>总股本未变，不是75股变1股吗？","listText":"<a href=\"https://laohu8.com/S/WLL\">$Whiting Petroleum Corp(WLL)$</a>总股本未变，不是75股变1股吗？","text":"$Whiting Petroleum Corp(WLL)$总股本未变，不是75股变1股吗？","images":[{"img":"https://static.tigerbbs.com/75291980245748c490eee68bb06f1b99","width":"1125","height":"2436"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":8,"repostSize":0,"link":"https://laohu8.com/post/978038598","isVote":1,"tweetType":1,"viewCount":2533,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3533084678796733","authorId":"3533084678796733","name":"給你壹个韭菜包","avatar":"https://static.tigerbbs.com/7f738c869c9e22180516f2e2b4baffd5","crmLevel":2,"crmLevelSwitch":0,"idStr":"3533084678796733","authorIdStr":"3533084678796733"},"content":"明天就变了","text":"明天就变了","html":"明天就变了"}],"imageCount":2,"langContent":"CN","totalScore":0},{"id":957727429,"gmtCreate":1593587857261,"gmtModify":1704202446784,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IVR\">$景顺抵押资本(IVR)$</a>确定过信息，被套路了[捂脸]&nbsp;","listText":"<a href=\"https://laohu8.com/S/IVR\">$景顺抵押资本(IVR)$</a>确定过信息，被套路了[捂脸]&nbsp;","text":"$景顺抵押资本(IVR)$确定过信息，被套路了[捂脸]","images":[{"img":"https://static.tigerbbs.com/45c53e81e5890c75980303cf667e0e26","width":"1125","height":"2436"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/957727429","isVote":1,"tweetType":1,"viewCount":2278,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3540509684886484","authorId":"3540509684886484","name":"拜登怂包","avatar":"https://static.tigerbbs.com/735fdbe85c4614a2fa6d8f12fe9445ad","crmLevel":7,"crmLevelSwitch":0,"idStr":"3540509684886484","authorIdStr":"3540509684886484"},"content":"老虎太缺德了，我也是上当受骗了，上午账上多了5千刀，现在又拿回去了，说分股，现金扣税了？有这么多税？","text":"老虎太缺德了，我也是上当受骗了，上午账上多了5千刀，现在又拿回去了，说分股，现金扣税了？有这么多税？","html":"老虎太缺德了，我也是上当受骗了，上午账上多了5千刀，现在又拿回去了，说分股，现金扣税了？有这么多税？"}],"imageCount":2,"langContent":"CN","totalScore":0},{"id":953163616,"gmtCreate":1590157909235,"gmtModify":1704192083562,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"割韭菜","listText":"割韭菜","text":"割韭菜","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/953163616","repostId":"1106155043","repostType":4,"isVote":1,"tweetType":1,"viewCount":994,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":925881293,"gmtCreate":1587970483212,"gmtModify":1704365882009,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MFA\">$MFA Financial(MFA)$</a><a href=\"https://laohu8.com/S/IVR\">$景顺抵押资本(IVR)$</a>这个有利好吗？","listText":"<a href=\"https://laohu8.com/S/MFA\">$MFA Financial(MFA)$</a><a href=\"https://laohu8.com/S/IVR\">$景顺抵押资本(IVR)$</a>这个有利好吗？","text":"$MFA Financial(MFA)$$景顺抵押资本(IVR)$这个有利好吗？","images":[{"img":"https://static.tigerbbs.com/caef110ab17566953cf63376fcb62307","width":"1125","height":"1075"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/925881293","isVote":1,"tweetType":1,"viewCount":1813,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":923797072,"gmtCreate":1585923171596,"gmtModify":1704359766715,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MFA\">$MFA Financial(MFA)$</a>出了什么事，怎么突然涨起来了？","listText":"<a href=\"https://laohu8.com/S/MFA\">$MFA Financial(MFA)$</a>出了什么事，怎么突然涨起来了？","text":"$MFA Financial(MFA)$出了什么事，怎么突然涨起来了？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/923797072","isVote":1,"tweetType":1,"viewCount":4742,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":978038598,"gmtCreate":1599059790014,"gmtModify":1704221353581,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/WLL\">$Whiting Petroleum Corp(WLL)$</a>总股本未变，不是75股变1股吗？","listText":"<a href=\"https://laohu8.com/S/WLL\">$Whiting Petroleum Corp(WLL)$</a>总股本未变，不是75股变1股吗？","text":"$Whiting Petroleum Corp(WLL)$总股本未变，不是75股变1股吗？","images":[{"img":"https://static.tigerbbs.com/75291980245748c490eee68bb06f1b99","width":"1125","height":"2436"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":8,"repostSize":0,"link":"https://laohu8.com/post/978038598","isVote":1,"tweetType":1,"viewCount":2533,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3533084678796733","authorId":"3533084678796733","name":"給你壹个韭菜包","avatar":"https://static.tigerbbs.com/7f738c869c9e22180516f2e2b4baffd5","crmLevel":2,"crmLevelSwitch":0,"idStr":"3533084678796733","authorIdStr":"3533084678796733"},"content":"明天就变了","text":"明天就变了","html":"明天就变了"}],"imageCount":2,"langContent":"CN","totalScore":0},{"id":957727429,"gmtCreate":1593587857261,"gmtModify":1704202446784,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IVR\">$景顺抵押资本(IVR)$</a>确定过信息，被套路了[捂脸]&nbsp;","listText":"<a href=\"https://laohu8.com/S/IVR\">$景顺抵押资本(IVR)$</a>确定过信息，被套路了[捂脸]&nbsp;","text":"$景顺抵押资本(IVR)$确定过信息，被套路了[捂脸]","images":[{"img":"https://static.tigerbbs.com/45c53e81e5890c75980303cf667e0e26","width":"1125","height":"2436"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/957727429","isVote":1,"tweetType":1,"viewCount":2278,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3540509684886484","authorId":"3540509684886484","name":"拜登怂包","avatar":"https://static.tigerbbs.com/735fdbe85c4614a2fa6d8f12fe9445ad","crmLevel":7,"crmLevelSwitch":0,"idStr":"3540509684886484","authorIdStr":"3540509684886484"},"content":"老虎太缺德了，我也是上当受骗了，上午账上多了5千刀，现在又拿回去了，说分股，现金扣税了？有这么多税？","text":"老虎太缺德了，我也是上当受骗了，上午账上多了5千刀，现在又拿回去了，说分股，现金扣税了？有这么多税？","html":"老虎太缺德了，我也是上当受骗了，上午账上多了5千刀，现在又拿回去了，说分股，现金扣税了？有这么多税？"}],"imageCount":2,"langContent":"CN","totalScore":0},{"id":105610942,"gmtCreate":1620297042686,"gmtModify":1620297042686,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"蟑狼要被气哭，销量怎么还这么好😄","listText":"蟑狼要被气哭，销量怎么还这么好😄","text":"蟑狼要被气哭，销量怎么还这么好😄","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/105610942","repostId":"1199027482","repostType":2,"repost":{"id":"1199027482","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1620296747,"share":"https://www.laohu8.com/m/news/1199027482?lang=&edition=full","pubTime":"2021-05-06 18:25","market":"us","language":"zh","title":"外媒：特斯拉需求异常强劲，第二季度产能已经售罄","url":"https://stock-news.laohu8.com/highlight/detail?id=1199027482","media":"老虎资讯综合","summary":"据ELECTREK：目前$特斯拉(TSLA)$的汽车需求异常强劲，第二季度产能已经售罄。\n\n预计特斯拉本季度的产能将略高于上季度180338辆的创纪录产量。\n\n特斯拉盘前快速上扬，截至发稿涨超2%。","content":"<p>据ELECTREK：目前<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>的汽车需求异常强劲，第二季度产能已经售罄。</p><p>预计特斯拉本季度的产能将略高于上季度180338辆的创纪录产量。</p><p>特斯拉盘前快速上扬，截至发稿涨超2%。</p><p><img src=\"https://static.tigerbbs.com/4e50a2878cdaa5cadb86565dfadbdd2a\" tg-width=\"600\" tg-height=\"373\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>外媒：特斯拉需求异常强劲，第二季度产能已经售罄</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n外媒：特斯拉需求异常强劲，第二季度产能已经售罄\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-05-06 18:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>据ELECTREK：目前<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>的汽车需求异常强劲，第二季度产能已经售罄。</p><p>预计特斯拉本季度的产能将略高于上季度180338辆的创纪录产量。</p><p>特斯拉盘前快速上扬，截至发稿涨超2%。</p><p><img src=\"https://static.tigerbbs.com/4e50a2878cdaa5cadb86565dfadbdd2a\" tg-width=\"600\" tg-height=\"373\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/2ba18e4c173130d8ec828f5035d30189","relate_stocks":{"TSLA":"特斯拉"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199027482","content_text":"据ELECTREK：目前特斯拉的汽车需求异常强劲，第二季度产能已经售罄。预计特斯拉本季度的产能将略高于上季度180338辆的创纪录产量。特斯拉盘前快速上扬，截至发稿涨超2%。","news_type":1},"isVote":1,"tweetType":1,"viewCount":2132,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":923797072,"gmtCreate":1585923171596,"gmtModify":1704359766715,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MFA\">$MFA Financial(MFA)$</a>出了什么事，怎么突然涨起来了？","listText":"<a href=\"https://laohu8.com/S/MFA\">$MFA Financial(MFA)$</a>出了什么事，怎么突然涨起来了？","text":"$MFA Financial(MFA)$出了什么事，怎么突然涨起来了？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/923797072","isVote":1,"tweetType":1,"viewCount":4742,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":108711974,"gmtCreate":1620053993698,"gmtModify":1620053993698,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VAL\">$华仕伯(VAL)$</a>终于重组成功了！有票的兄弟是不是被清零了？","listText":"<a href=\"https://laohu8.com/S/VAL\">$华仕伯(VAL)$</a>终于重组成功了！有票的兄弟是不是被清零了？","text":"$华仕伯(VAL)$终于重组成功了！有票的兄弟是不是被清零了？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/108711974","isVote":1,"tweetType":1,"viewCount":4872,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3548566245371949","authorId":"3548566245371949","name":"wzxmypwj","avatar":"https://static.tigerbbs.com/f749249dd00b0c60c84b12290ccec6a4","crmLevel":2,"crmLevelSwitch":0,"idStr":"3548566245371949","authorIdStr":"3548566245371949"},"content":"在粉单，但是粉单也退市无法交易了，只能等消息","text":"在粉单，但是粉单也退市无法交易了，只能等消息","html":"在粉单，但是粉单也退市无法交易了，只能等消息"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":389641008,"gmtCreate":1612772265004,"gmtModify":1703764779808,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"格局限制，也只能做国内的B站","listText":"格局限制，也只能做国内的B站","text":"格局限制，也只能做国内的B站","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/389641008","repostId":"2109746767","repostType":2,"isVote":1,"tweetType":1,"viewCount":2145,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":925881293,"gmtCreate":1587970483212,"gmtModify":1704365882009,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MFA\">$MFA Financial(MFA)$</a><a href=\"https://laohu8.com/S/IVR\">$景顺抵押资本(IVR)$</a>这个有利好吗？","listText":"<a href=\"https://laohu8.com/S/MFA\">$MFA Financial(MFA)$</a><a href=\"https://laohu8.com/S/IVR\">$景顺抵押资本(IVR)$</a>这个有利好吗？","text":"$MFA Financial(MFA)$$景顺抵押资本(IVR)$这个有利好吗？","images":[{"img":"https://static.tigerbbs.com/caef110ab17566953cf63376fcb62307","width":"1125","height":"1075"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/925881293","isVote":1,"tweetType":1,"viewCount":1813,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":139045016,"gmtCreate":1621578681735,"gmtModify":1621578681735,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"滑而不为，徒有其名","listText":"滑而不为，徒有其名","text":"滑而不为，徒有其名","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/139045016","repostId":"1158351998","repostType":4,"repost":{"id":"1158351998","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1621574806,"share":"https://www.laohu8.com/m/news/1158351998?lang=&edition=full","pubTime":"2021-05-21 13:26","market":"us","language":"zh","title":"华为将扩大与长安汽车的智能汽车合作伙伴关系，以研发芯片","url":"https://stock-news.laohu8.com/highlight/detail?id=1158351998","media":"老虎资讯综合","summary":"5月21日，华为将扩大与汽车制造商长安汽车的智能汽车合作伙伴关系，以研发芯片。据四位知情人士透露，华为正在扩大与重庆长安汽车的智能汽车合作伙伴关系，包括汽车用半导体的设计和开发。两位消息人士称，两家公","content":"<p>5月21日，华为将扩大与汽车制造商长安汽车的智能汽车合作伙伴关系，以研发芯片。</p><p>据四位知情人士透露，华为正在扩大与重庆长安汽车的智能汽车合作伙伴关系，包括汽车用半导体的设计和开发。两位消息人士称，两家公司在去年11月公布了智能汽车合作计划，过去几个月一直在芯片方面非正式合作。另一位消息人士称，他们可能很快就会成立一家芯片开发合资企业。</p><p>对此长安汽车有关部门回应：我们(和华为)主要合作的是全新平台的开发，以及品牌的合作。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>华为将扩大与长安汽车的智能汽车合作伙伴关系，以研发芯片</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n华为将扩大与长安汽车的智能汽车合作伙伴关系，以研发芯片\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-05-21 13:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>5月21日，华为将扩大与汽车制造商长安汽车的智能汽车合作伙伴关系，以研发芯片。</p><p>据四位知情人士透露，华为正在扩大与重庆长安汽车的智能汽车合作伙伴关系，包括汽车用半导体的设计和开发。两位消息人士称，两家公司在去年11月公布了智能汽车合作计划，过去几个月一直在芯片方面非正式合作。另一位消息人士称，他们可能很快就会成立一家芯片开发合资企业。</p><p>对此长安汽车有关部门回应：我们(和华为)主要合作的是全新平台的开发，以及品牌的合作。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/7f0607d088fd08637f4d6d330897aafb","relate_stocks":{},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158351998","content_text":"5月21日，华为将扩大与汽车制造商长安汽车的智能汽车合作伙伴关系，以研发芯片。据四位知情人士透露，华为正在扩大与重庆长安汽车的智能汽车合作伙伴关系，包括汽车用半导体的设计和开发。两位消息人士称，两家公司在去年11月公布了智能汽车合作计划，过去几个月一直在芯片方面非正式合作。另一位消息人士称，他们可能很快就会成立一家芯片开发合资企业。对此长安汽车有关部门回应：我们(和华为)主要合作的是全新平台的开发，以及品牌的合作。","news_type":1},"isVote":1,"tweetType":1,"viewCount":2107,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":889008878,"gmtCreate":1631088317794,"gmtModify":1631088317794,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"特斯拉上海工厂大多数产能都出口欧洲市场，等该死的德国工厂建成出产能就是血洗国内三傻的时候！","listText":"特斯拉上海工厂大多数产能都出口欧洲市场，等该死的德国工厂建成出产能就是血洗国内三傻的时候！","text":"特斯拉上海工厂大多数产能都出口欧洲市场，等该死的德国工厂建成出产能就是血洗国内三傻的时候！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/889008878","repostId":"1199548550","repostType":4,"repost":{"id":"1199548550","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631087792,"share":"https://www.laohu8.com/m/news/1199548550?lang=&edition=full","pubTime":"2021-09-08 15:56","market":"us","language":"zh","title":"乘联会：特斯拉中国8月销售44264辆，比亚迪60858辆","url":"https://stock-news.laohu8.com/highlight/detail?id=1199548550","media":"老虎资讯综合","summary":"乘联会：8月新能源乘用车批发销量达到30.4万辆，同比增长202.3%，环比增长23.7%。1-8月新能源乘用车批发164.3万辆，同比增长222.5%。8月新能源乘用车零售销量达到24.9万辆，同比","content":"<p>乘联会：8月新能源乘用车批发销量达到30.4万辆，同比增长202.3%，环比增长23.7%。1-8月新能源乘用车批发164.3万辆，同比增长222.5%。8月新能源乘用车零售销量达到24.9万辆，同比增长167.5%，环比增12.0%。1-8月新能源车零售147.9万辆，同比增长202.1%。与传统燃油车走势形成强烈差异化的特征，实现对燃油车市场的替代效应，并拉动车市向新能源化转型的步伐。</p>\n<p>乘联会数据显示，2021年8月乘用车市场零售达到145.3万辆，同比下降14.7%，而且相较2019年8月下降7%，增速偏弱。今年1-8月的零售累计达到1290.0万辆，同比增长17.1%，较1-7月增速下降6个百分点。减速的原因主要是2020年7-8月零售高基数的影响。今年1-8月同比增量188万辆中的新能源车增量就达100万辆，占总增量54% 对1-8月同比增速贡献了9个百分点。</p>\n<p>8月新能源车出口呈现爆发式增长，特斯拉中国出口31,379辆，上汽乘用车的新能源出口4,074辆，比亚迪781辆，爱驰汽车103辆，其他车企新能源车出口也正蓄势待发。2021年比利时成为中国最大汽车出口地。</p>\n<p>8月理想、小鹏、蔚来、合众、零跑等新势力车企销量同比和环比表现总体都很优秀，尤其是哪吒、零跑等二线新势力逐步崛起。主流合资品牌中的南北大众的新能源车批发11,756辆，占据主流合资69%份额。</p>\n<p>8月新能源乘用车市场多元化发力，大集团新能源表现分化，上汽、广汽表现相对较强。厂商批发销量突破万辆的企业有：比亚迪60,858辆、特斯拉中国44,264辆、上汽通用五菱43,783辆、上汽乘用车16,998辆、广汽埃安11,613辆。8月插电混动的比亚迪销量达到30,476辆，环比增长24%，推动平价插电混动增长成新亮点。</p>\n<p>乘联会：随着合资与豪华车企的芯片持续供给不足，加之新能源车的连续火爆，自主品牌的产销也将明显提升，体现了自主品牌供应链自主可控的产业优势。</p>\n<p></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>乘联会：特斯拉中国8月销售44264辆，比亚迪60858辆</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n乘联会：特斯拉中国8月销售44264辆，比亚迪60858辆\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-09-08 15:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>乘联会：8月新能源乘用车批发销量达到30.4万辆，同比增长202.3%，环比增长23.7%。1-8月新能源乘用车批发164.3万辆，同比增长222.5%。8月新能源乘用车零售销量达到24.9万辆，同比增长167.5%，环比增12.0%。1-8月新能源车零售147.9万辆，同比增长202.1%。与传统燃油车走势形成强烈差异化的特征，实现对燃油车市场的替代效应，并拉动车市向新能源化转型的步伐。</p>\n<p>乘联会数据显示，2021年8月乘用车市场零售达到145.3万辆，同比下降14.7%，而且相较2019年8月下降7%，增速偏弱。今年1-8月的零售累计达到1290.0万辆，同比增长17.1%，较1-7月增速下降6个百分点。减速的原因主要是2020年7-8月零售高基数的影响。今年1-8月同比增量188万辆中的新能源车增量就达100万辆，占总增量54% 对1-8月同比增速贡献了9个百分点。</p>\n<p>8月新能源车出口呈现爆发式增长，特斯拉中国出口31,379辆，上汽乘用车的新能源出口4,074辆，比亚迪781辆，爱驰汽车103辆，其他车企新能源车出口也正蓄势待发。2021年比利时成为中国最大汽车出口地。</p>\n<p>8月理想、小鹏、蔚来、合众、零跑等新势力车企销量同比和环比表现总体都很优秀，尤其是哪吒、零跑等二线新势力逐步崛起。主流合资品牌中的南北大众的新能源车批发11,756辆，占据主流合资69%份额。</p>\n<p>8月新能源乘用车市场多元化发力，大集团新能源表现分化，上汽、广汽表现相对较强。厂商批发销量突破万辆的企业有：比亚迪60,858辆、特斯拉中国44,264辆、上汽通用五菱43,783辆、上汽乘用车16,998辆、广汽埃安11,613辆。8月插电混动的比亚迪销量达到30,476辆，环比增长24%，推动平价插电混动增长成新亮点。</p>\n<p>乘联会：随着合资与豪华车企的芯片持续供给不足，加之新能源车的连续火爆，自主品牌的产销也将明显提升，体现了自主品牌供应链自主可控的产业优势。</p>\n<p></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/edb5904d62b10798f760277be625646d","relate_stocks":{"TSLA":"特斯拉","002594":"比亚迪"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199548550","content_text":"乘联会：8月新能源乘用车批发销量达到30.4万辆，同比增长202.3%，环比增长23.7%。1-8月新能源乘用车批发164.3万辆，同比增长222.5%。8月新能源乘用车零售销量达到24.9万辆，同比增长167.5%，环比增12.0%。1-8月新能源车零售147.9万辆，同比增长202.1%。与传统燃油车走势形成强烈差异化的特征，实现对燃油车市场的替代效应，并拉动车市向新能源化转型的步伐。\n乘联会数据显示，2021年8月乘用车市场零售达到145.3万辆，同比下降14.7%，而且相较2019年8月下降7%，增速偏弱。今年1-8月的零售累计达到1290.0万辆，同比增长17.1%，较1-7月增速下降6个百分点。减速的原因主要是2020年7-8月零售高基数的影响。今年1-8月同比增量188万辆中的新能源车增量就达100万辆，占总增量54% 对1-8月同比增速贡献了9个百分点。\n8月新能源车出口呈现爆发式增长，特斯拉中国出口31,379辆，上汽乘用车的新能源出口4,074辆，比亚迪781辆，爱驰汽车103辆，其他车企新能源车出口也正蓄势待发。2021年比利时成为中国最大汽车出口地。\n8月理想、小鹏、蔚来、合众、零跑等新势力车企销量同比和环比表现总体都很优秀，尤其是哪吒、零跑等二线新势力逐步崛起。主流合资品牌中的南北大众的新能源车批发11,756辆，占据主流合资69%份额。\n8月新能源乘用车市场多元化发力，大集团新能源表现分化，上汽、广汽表现相对较强。厂商批发销量突破万辆的企业有：比亚迪60,858辆、特斯拉中国44,264辆、上汽通用五菱43,783辆、上汽乘用车16,998辆、广汽埃安11,613辆。8月插电混动的比亚迪销量达到30,476辆，环比增长24%，推动平价插电混动增长成新亮点。\n乘联会：随着合资与豪华车企的芯片持续供给不足，加之新能源车的连续火爆，自主品牌的产销也将明显提升，体现了自主品牌供应链自主可控的产业优势。","news_type":1},"isVote":1,"tweetType":1,"viewCount":2720,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":953163616,"gmtCreate":1590157909235,"gmtModify":1704192083562,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"割韭菜","listText":"割韭菜","text":"割韭菜","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/953163616","repostId":"1106155043","repostType":4,"isVote":1,"tweetType":1,"viewCount":994,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":331438031,"gmtCreate":1609746419023,"gmtModify":1703740159532,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"台积电2021年产能铺满，没有多余产能了","listText":"台积电2021年产能铺满，没有多余产能了","text":"台积电2021年产能铺满，没有多余产能了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/331438031","repostId":"2100637027","repostType":2,"repost":{"id":"2100637027","pubTimestamp":1609560970,"share":"https://www.laohu8.com/m/news/2100637027?lang=&edition=full","pubTime":"2021-01-02 12:16","market":"us","language":"zh","title":"ASML传来坏消息！张忠谋：国产光刻机迎来磨难，台积电首当其冲","url":"https://stock-news.laohu8.com/highlight/detail?id=2100637027","media":"星新看世界","summary":"任正非先生此前表示，国内的基础制造无法生产麒麟芯片，这也揭示了华为当前的尴尬状况，同时也彰显了光刻机这项技术的重要性。目前可以制造高级芯片的光刻机只能由荷兰的ASML集团生产。可以说，如果没有ASML的EUV光刻机，台积电和三星都将无法生产高端芯片。所以才会说ASML集团传来的是一个坏消息，国内的光刻机将迎来磨难，而台积电无疑是首当其冲的。","content":"<html><body><article><p>美国针对我们国家的芯片禁令暴露了我们国家很多的问题，其实华为已经是拥有了设计世界顶尖芯片的能力，但是没有办法，制造芯片最重要的光刻机技术掌握在西方国家的手中，所以即便华为拥有设计顶级芯片的能力，但是仍然受制于光刻机技术的缺失。</p><img src=\"https://fid-75186.picgzc.qpic.cn/20210102152423449v1734glim02bisv\"/><p>主要还是因为我们国家在光刻机技术领域发展的比较晚，所以才会受到美国的掣肘。任正非先生此前表示，国内的基础制造无法生产麒麟芯片，这也揭示了华为当前的尴尬状况，同时也彰显了光刻机这项技术的重要性。</p><img src=\"https://fid-75186.picgzc.qpic.cn/20210102152428518v173kcq35y0vown\"/><p>ASML传来坏消息！张忠谋：国产光刻机迎来磨难，<a href=\"https://laohu8.com/S/TSM\">台积电</a>首当其冲！目前可以制造高级芯片的光刻机只能由荷兰的ASML集团生产。ASML集团在光刻机领域有着绝对的话语权，然而，即便如此，因为ASML集团很多的核心技术都是美国支撑着，所以也只能听从美国的指令。</p><img src=\"https://fid-75186.picgzc.qpic.cn/20210102152430047v173imsbrwedl05\"/><p>可以说，如果没有ASML的EUV光刻机，台积电和<a href=\"https://laohu8.com/S/SMSN.UK\">三星</a>都将无法生产高端芯片。可是，最近又有一个不好的消息，ASML开发的NA EUV光刻机已经完成了基本设计，并很快就能够实现商业化，这个新光刻机将能够用于生产2nm甚至1nm工艺芯片。</p><img src=\"https://fid-75186.picgzc.qpic.cn/20210102152439687v173lfz7iszkq3c\"/><p>可是，国产光刻机才刚刚勉强突破到7nm的层次，如今ASML集团的光刻机技术就再次突破，那么我们国家想要在光刻机技术上面追赶上来，难度再次增大了。此外，一台NA EUV光刻机的售价高达4.5亿美元，台积电是ASML集团最大的客户，但是台积电的实力不太能够吃得消这么昂贵的设备。</p><img src=\"https://inews.gtimg.com/newsapp_bt/0/12990156537/1000\"/><p>毕竟台积电刚刚失去了华为这个大客户，再加上<a href=\"https://laohu8.com/S/QCOM\">高通</a>和<a href=\"https://laohu8.com/S/INTC\">英特尔</a>的订单又被三星抢走了，台积电的利润下降的同时，设备的成本还增加了，这令台积电陷入了一个两难境地。而台积电的对手三星财大气粗，反而可以大肆购买现金设备，从而不断抢占台积电的市场。所以才会说ASML集团传来的是一个坏消息，国内的光刻机将迎来磨难，而台积电无疑是首当其冲的。</p></article></body></html>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ASML传来坏消息！张忠谋：国产光刻机迎来磨难，台积电首当其冲</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nASML传来坏消息！张忠谋：国产光刻机迎来磨难，台积电首当其冲\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-01-02 12:16 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021010215245677d80fde&s=b><strong>星新看世界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>美国针对我们国家的芯片禁令暴露了我们国家很多的问题，其实华为已经是拥有了设计世界顶尖芯片的能力，但是没有办法，制造芯片最重要的光刻机技术掌握在西方国家的手中，所以即便华为拥有设计顶级芯片的能力，但是仍然受制于光刻机技术的缺失。主要还是因为我们国家在光刻机技术领域发展的比较晚，所以才会受到美国的掣肘。任正非先生此前表示，国内的基础制造无法生产麒麟芯片，这也揭示了华为当前的尴尬状况，同时也彰显了光刻机...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021010215245677d80fde&s=b\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/975836d8c6eb511241583dccb0d387f2","relate_stocks":{"EWT":"台湾ETF-iShares MSCI","TSM":"台积电","03145":"华夏亚洲高息股"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021010215245677d80fde&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2100637027","content_text":"美国针对我们国家的芯片禁令暴露了我们国家很多的问题，其实华为已经是拥有了设计世界顶尖芯片的能力，但是没有办法，制造芯片最重要的光刻机技术掌握在西方国家的手中，所以即便华为拥有设计顶级芯片的能力，但是仍然受制于光刻机技术的缺失。主要还是因为我们国家在光刻机技术领域发展的比较晚，所以才会受到美国的掣肘。任正非先生此前表示，国内的基础制造无法生产麒麟芯片，这也揭示了华为当前的尴尬状况，同时也彰显了光刻机这项技术的重要性。ASML传来坏消息！张忠谋：国产光刻机迎来磨难，台积电首当其冲！目前可以制造高级芯片的光刻机只能由荷兰的ASML集团生产。ASML集团在光刻机领域有着绝对的话语权，然而，即便如此，因为ASML集团很多的核心技术都是美国支撑着，所以也只能听从美国的指令。可以说，如果没有ASML的EUV光刻机，台积电和三星都将无法生产高端芯片。可是，最近又有一个不好的消息，ASML开发的NA EUV光刻机已经完成了基本设计，并很快就能够实现商业化，这个新光刻机将能够用于生产2nm甚至1nm工艺芯片。可是，国产光刻机才刚刚勉强突破到7nm的层次，如今ASML集团的光刻机技术就再次突破，那么我们国家想要在光刻机技术上面追赶上来，难度再次增大了。此外，一台NA EUV光刻机的售价高达4.5亿美元，台积电是ASML集团最大的客户，但是台积电的实力不太能够吃得消这么昂贵的设备。毕竟台积电刚刚失去了华为这个大客户，再加上高通和英特尔的订单又被三星抢走了，台积电的利润下降的同时，设备的成本还增加了，这令台积电陷入了一个两难境地。而台积电的对手三星财大气粗，反而可以大肆购买现金设备，从而不断抢占台积电的市场。所以才会说ASML集团传来的是一个坏消息，国内的光刻机将迎来磨难，而台积电无疑是首当其冲的。","news_type":1},"isVote":1,"tweetType":1,"viewCount":3248,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":396365893,"gmtCreate":1607045792812,"gmtModify":1703846098321,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/00282\">$壹传媒(00282)$</a>又涨了[笑哭]&nbsp;","listText":"<a href=\"https://laohu8.com/S/00282\">$壹传媒(00282)$</a>又涨了[笑哭]&nbsp;","text":"$壹传媒(00282)$又涨了[笑哭]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/396365893","isVote":1,"tweetType":1,"viewCount":2358,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":303562759,"gmtCreate":1603201566171,"gmtModify":1703829046519,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VAL\">$华仕伯(VAL)$</a>怎么从退市变成停牌了？","listText":"<a href=\"https://laohu8.com/S/VAL\">$华仕伯(VAL)$</a>怎么从退市变成停牌了？","text":"$华仕伯(VAL)$怎么从退市变成停牌了？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/303562759","isVote":1,"tweetType":1,"viewCount":2318,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":281246745047152,"gmtCreate":1709694273768,"gmtModify":1709694275503,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"鸡你太美就等着开源呢","listText":"鸡你太美就等着开源呢","text":"鸡你太美就等着开源呢","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/281246745047152","repostId":"1163823659","repostType":2,"isVote":1,"tweetType":1,"viewCount":738,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":894951236,"gmtCreate":1628784658825,"gmtModify":1628784658825,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"华为拷贝部马上加班拷贝[开心]&nbsp;","listText":"华为拷贝部马上加班拷贝[开心]&nbsp;","text":"华为拷贝部马上加班拷贝[开心]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/894951236","repostId":"2158126892","repostType":2,"repost":{"id":"2158126892","pubTimestamp":1628779606,"share":"https://www.laohu8.com/m/news/2158126892?lang=&edition=full","pubTime":"2021-08-12 22:46","market":"us","language":"zh","title":"苹果新专利：把Apple Pencil放在电脑里","url":"https://stock-news.laohu8.com/highlight/detail?id=2158126892","media":"肖瘦人","summary":"8月12日消息，美国专利商标局公布了苹果的一项专利申请，该申请涉及MacBook的新输入系统。苹果这项发明在MacBook键盘上设置了一个带传感器的固定槽，用来固定Apple Pencil，固定槽位于键盘F键一行区域，通过一套“透明系统”，触摸Apple Pencil的不同位置可以激活相应的...","content":"<html><body><div>\n<div itemprop=\"articleBody\">\n<img src=\"https://article-fd.zol-img.com.cn/t_s640x2000/g6/M00/0B/04/ChMkKWEVNWWIOtODAAJJf14wS2sAAStygC_tTcAAkmX073.jpg\"/><div>\n<div><div></div></div>\n</div>\n<p>8月12日消息，美国专利商标局公布了<a href=\"https://laohu8.com/S/AAPL\">苹果</a>的一项专利申请，该申请涉及MacBook的新输入系统。</p><p>苹果这项发明在MacBook键盘上设置了一个带传感器的固定槽，用来固定Apple Pencil，固定槽位于键盘F键一行区域，通过一套“透明系统”，触摸Apple Pencil的不同位置可以激活相应的F键。另外，Apple Pencil可以在固定状态也可以替代部分鼠标的功能。</p><p>这一专利落实到产品上的概率并不会很大，只是代表苹果曾经思考/测试过这些功能，甚至只是奇思妙想。</p><p><span></span><img height=\"1108\" src=\"https://article-fd.zol-img.com.cn/t_s640x2000/g6/M00/0B/04/ChMkKWEVNWWIOtODAAJJf14wS2sAAStygC_tTcAAkmX073.jpg\" width=\"640\"/></p><p>本文属于原创文章，如若转载，请注明来源：苹果新专利：把Apple Pencil放在电脑里https://news.zol.com.cn/774/7745465.html</p><div zpv-events-inview=\"article-cont-bottom-viewport\"></div>\n<div>\n<span itemprop=\"url\">https://news.zol.com.cn/774/7745465.html</span>\n<span itemprop=\"indexUrl\">news.zol.com.cn</span>\n<span itemprop=\"isOriginal\">true</span>\n<span itemprop=\"author\"><a href=\"https://laohu8.com/S/000931\">中关村</a>在线</span>\n<span itemprop=\"isBasedOnUrl\">https://news.zol.com.cn/774/7745465.html</span>\n<span itemprop=\"genre\">report</span>\n<span itemprop=\"wordCount\">406</span>\n<span itemprop=\"description\">8月12日消息，美国专利商标局公布了苹果的一项专利申请，该申请涉及MacBook的新输入系统。苹果这项发明在MacBook键盘上设置了一个带传感器的固定槽，用来固定Apple Pencil，固定槽位于键盘F键一行区域，通过一套“透明系统”，触摸Apple Pencil的不同位置可以激活相应的...</span>\n</div></div>\n</div></body></html>","source":"zol_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>苹果新专利：把Apple Pencil放在电脑里</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n苹果新专利：把Apple Pencil放在电脑里\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-12 22:46 北京时间&nbsp;&nbsp;&nbsp;<a href=http://news.zol.com.cn/774/7745465.html><strong>肖瘦人</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>8月12日消息，美国专利商标局公布了苹果的一项专利申请，该申请涉及MacBook的新输入系统。苹果这项发明在MacBook键盘上设置了一个带传感器的固定槽，用来固定Apple Pencil，固定槽位于键盘F键一行区域，通过一套“透明系统”，触摸Apple Pencil的不同位置可以激活相应的F键。另外，Apple Pencil可以在固定状态也可以替代部分鼠标的功能。这一专利落实到产品上的概率并不会...</p>\n\n<a href=\"http://news.zol.com.cn/774/7745465.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/add5f090cc383f46b0c3a1d49fc9edc5","relate_stocks":{"AAPL":"苹果"},"source_url":"http://news.zol.com.cn/774/7745465.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158126892","content_text":"8月12日消息，美国专利商标局公布了苹果的一项专利申请，该申请涉及MacBook的新输入系统。苹果这项发明在MacBook键盘上设置了一个带传感器的固定槽，用来固定Apple Pencil，固定槽位于键盘F键一行区域，通过一套“透明系统”，触摸Apple Pencil的不同位置可以激活相应的F键。另外，Apple Pencil可以在固定状态也可以替代部分鼠标的功能。这一专利落实到产品上的概率并不会很大，只是代表苹果曾经思考/测试过这些功能，甚至只是奇思妙想。本文属于原创文章，如若转载，请注明来源：苹果新专利：把Apple Pencil放在电脑里https://news.zol.com.cn/774/7745465.html\n\nhttps://news.zol.com.cn/774/7745465.html\nnews.zol.com.cn\ntrue\n中关村在线\nhttps://news.zol.com.cn/774/7745465.html\nreport\n406\n8月12日消息，美国专利商标局公布了苹果的一项专利申请，该申请涉及MacBook的新输入系统。苹果这项发明在MacBook键盘上设置了一个带传感器的固定槽，用来固定Apple Pencil，固定槽位于键盘F键一行区域，通过一套“透明系统”，触摸Apple Pencil的不同位置可以激活相应的...","news_type":1},"isVote":1,"tweetType":1,"viewCount":1591,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":972632481,"gmtCreate":1600199728243,"gmtModify":1703820725001,"author":{"id":"3547114025989487","authorId":"3547114025989487","name":"自由君","avatar":"https://static.tigerbbs.com/f249506f773b7df167d4defbae98dca7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547114025989487","authorIdStr":"3547114025989487"},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/972632481","repostId":"2066210025","repostType":2,"repost":{"id":"2066210025","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1599586620,"share":"https://www.laohu8.com/m/news/2066210025?lang=&edition=full","pubTime":"2020-09-09 01:37","market":"us","language":"en","title":"There are seven coronavirus vaccine candidates being tested in the U.S. -- here's where they stand","url":"https://stock-news.laohu8.com/highlight/detail?id=2066210025","media":"Dow Jones","summary":"MW UPDATE: There are seven coronavirus vaccine candidates being tested in the U.S. -- here's where t","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW UPDATE: There are seven coronavirus vaccine candidates being tested in the U.S. -- here's where they stand\n</p>\n<p>\n  By Jaimy Lee \n</p>\n<p>\n  At least three of the still investigational vaccines have moved into Phase 3 clinical trials \n</p>\n<p>\n  The race to develop a safe and effective COVID-19 vaccine is well under way, setting the stage to bring to market the fastest vaccine in history. \n</p>\n<p>\n  There are dozens of coronavirus vaccines in development, primarily in the preclinical phase when they are tested on animals. In the U.S., there are seven vaccine candidates that have moved into clinical trials with human participants, including three that have moved into the crucial Phase 3 development phase. \n</p>\n<p>\n  The first and second phases of clinical studies are primarily conducted to test for safety, while the third and final stage is used to determine whether the vaccines are efficacious and can prevent infection among participants. At that point, the vaccine makers will decide when to pursue an emergency use authorization from the Food and Drug Administration and/or a full approval. The majority of the vaccines in development have received funding from the U.S. government, either to help support clinical development or pay for manufacturing and distribution of the vaccines as part of the Trump administration's Operation Warp Speed program. \n</p>\n<p>\n  MarketWatch will update this tally as the vaccines move through development. \n</p>\n<p>\n  Vaccines that have entered Phase 3 trials in the U.S. (cited in alphabetical order, by company name): \n</p>\n<p>\n  AstraZeneca, in partnership with the University of Oxford \n</p>\n<p>\n  Year-to-date stock performance:(AZN.LN) (AZN.LN) Up 7.8% \n</p>\n<p>\n  Name: AZD1222 \n</p>\n<p>\n  Type: Vector-based \n</p>\n<p>\n  Phase 1/2: Data from the Phase 1/2 trial, which is being conducted in the U.K., was published July 20 in The Lancet  neutralizing antibody responses in 91% of 35 patients when using <a href=\"https://laohu8.com/S/AONE.U\">one</a> test and 100% of 35 patients when using a different test. \n</p>\n<p>\n  Phase 3: This trial, which will be held in the U.S., is expected to enroll up to 30,000 participants. (Late-stage studies are also being conducted in Brazil, and South Africa, and the U.K.) Data is expected by the end of the year. \n</p>\n<p>\n  Clinical development and manufacturing funding from the U.S. government: up to $1.2 billion \n</p>\n<p>\n  U.S. dose promise: 300 million doses \n</p>\n<p>\n  Dosing: 2 doses \n</p>\n<p>\n  BioNTech  and Pfizer Inc. \n</p>\n<p>\n  Year-to-date stock performances: BioNTech<a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a>, up 75.0%; Pfizer<a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a>, down 8.3%. \n</p>\n<p>\n  Name: BNT162b2 \n</p>\n<p>\n  Type: mRNA \n</p>\n<p>\n  Phase 1: The companies published preliminary data on July 1 for BNT162b1 as a preprint  was published on Aug. 28 for BNT162b2 that found this candidate produced similar levels of antibodies but participants reported fewer reactions. \n</p>\n<p>\n    This trial is expected to focus on BNT162b2. It is expected to enroll up to 30,000 participants in Argentina, Brazil, and the U.S. \n</p>\n<p>\n  Manufacturing funding from the U.S. government: $1.95 billion \n</p>\n<p>\n  U.S. dose promise: 100 million doses, with option to buy up to 500 million more doses \n</p>\n<p>\n  Dosing: 2 doses \n</p>\n<p>\n  Moderna Inc. \n</p>\n<p>\n  Year-to-date stock performance:<a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> Up 187.8% \n</p>\n<p>\n  Name: mRNA-1273 \n</p>\n<p>\n  Type: mRNA \n</p>\n<p>\n  Phase 1 . Moderna's vaccine candidate elicited neutralizing antibodies in all 45 participants in this trial, which was conducted in the U.S. in partnership with the National Institute of Allergy and Infectious Diseases. \n</p>\n<p>\n  Phase 2a : This study closed enrollment of 600 participants on July 8. This trial is also focused on the U.S. \n</p>\n<p>\n  Phase 3 : This study is expected to complete enrollment of up to 30,000 people sometime in September. \n</p>\n<p>\n  R&amp;D funding from BARDA: $955 million \n</p>\n<p>\n  Supply funding from the U.S. government: Up to $1.525 billion \n</p>\n<p>\n  U.S. dose promise: 100 million, with option to acquire up 400 million additional doses \n</p>\n<p>\n  Dosing: 2 doses \n</p>\n<p>\n  Vaccines that have entered Phase 1 and 2 trials in the U.S. (cited in alphabetical order, by company name): \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/INO\">Inovio Pharmaceuticals Inc</a>. \n</p>\n<p>\n  Year-to-date stock performance:(INO)up 191.2% \n</p>\n<p>\n  Name: INO-4800 \n</p>\n<p>\n  Type: DNA \n</p>\n<p>\n  Phase 1  on June; it has not yet shared the full data but has submitted the results for publication in a peer-reviewed medical journal. The trial is being conducted in the U.S. \n</p>\n<p>\n  Phase 2/3: Inovio said Sept. 8 it plans to launch this phase of the study in September, if it is given the go-ahead by the FDA. \n</p>\n<p>\n  U.S. government funding: It received $71 million  from the Department of Defense to make and buy the devices that will be used to dispense the company's vaccine if it is authorized or approved. \n</p>\n<p>\n  Johnson &amp; Johnson \n</p>\n<p>\n  Year-to-date stock performance:<a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> Up 1.2% \n</p>\n<p>\n  Name: Ad26. COV2. S \n</p>\n<p>\n  Type: Vector-based \n</p>\n<p>\n  Phase 1/2a  in the second half of July, with a goal of enrolling 1,045 adults in Belgium and the U.S. \n</p>\n<p>\n  Phase 3: It plans to launch this trial in September. \n</p>\n<p>\n  R&amp;D funding from BARDA: $456 million \n</p>\n<p>\n  U.S. government funding for manufacturing and delivery:More than $1 billion  \n</p>\n<p>\n  U.S. dose promise: 100 million doses, with option to buy up to 200 million additional doses \n</p>\n<p>\n  Novavax Inc. \n</p>\n<p>\n  Year-to-date stock performance:<a href=\"https://laohu8.com/S/NVAX\">$(NVAX)$</a> Up 2,167.6% \n</p>\n<p>\n  Name: NVX-CoV2373 \n</p>\n<p>\n  Type: Protein subunit \n</p>\n<p>\n  Phase 1: . \n</p>\n<p>\n  Phase 1/2: The second phase of the Phase 1/2 trial started in August and will be conducted in Australia and the U.S. \n</p>\n<p>\n  Phase 3: TBD \n</p>\n<p>\n  Clinical development and manufacturing funding from the U.S. government:$1.6 billion  \n</p>\n<p>\n  U.S. dose promise: 100 million doses \n</p>\n<pre><table><tbody><tr><td></td><td>Sanofi</td><td>in combination with GlaxoSmithKline's (TICKER:GSK) (TICKER:UK:GSK)</td><td>adjuvant technology </td></tr></tbody></table></pre>\n<p>\n  Companies: \n</p>\n<p>\n  Year-to-date stock performance: Sanofi (SAN.FR)(SAN.FR) Up 0.6%. \n</p>\n<p>\n  Name: TBD \n</p>\n<p>\n  Type: Protein-based \n</p>\n<p>\n  Phase 1/2 study: The trial was initiated Sept. 3 , with a goal of enrolling 440 adults in the U.S. Results are expected in December. \n</p>\n<p>\n  Phase 3: This study is expected to launch by the \"end of 2020.\" \n</p>\n<p>\n  Clinical development and manufacturing funding from the U.S. government: Up to $2.1 billion \n</p>\n<p>\n  U.S. dose promise: Up to 100 million doses, with option to buy up to 500 million doses \n</p>\n<pre><table><tbody><tr><td>Sources: Company websites, federal data, the World Health Organization, RBC Capital Markets </td></tr></tbody></table></pre>\n<p>\n  -Jaimy Lee; 415-439-6400; AskNewswires@dowjones.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 08, 2020 13:37 ET (17:37 GMT)\n</p>\n<p>\n  Copyright (c) 2020 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>There are seven coronavirus vaccine candidates being tested in the U.S. -- here's where they stand</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThere are seven coronavirus vaccine candidates being tested in the U.S. -- here's where they stand\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2020-09-09 01:37</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW UPDATE: There are seven coronavirus vaccine candidates being tested in the U.S. -- here's where they stand\n</p>\n<p>\n  By Jaimy Lee \n</p>\n<p>\n  At least three of the still investigational vaccines have moved into Phase 3 clinical trials \n</p>\n<p>\n  The race to develop a safe and effective COVID-19 vaccine is well under way, setting the stage to bring to market the fastest vaccine in history. \n</p>\n<p>\n  There are dozens of coronavirus vaccines in development, primarily in the preclinical phase when they are tested on animals. In the U.S., there are seven vaccine candidates that have moved into clinical trials with human participants, including three that have moved into the crucial Phase 3 development phase. \n</p>\n<p>\n  The first and second phases of clinical studies are primarily conducted to test for safety, while the third and final stage is used to determine whether the vaccines are efficacious and can prevent infection among participants. At that point, the vaccine makers will decide when to pursue an emergency use authorization from the Food and Drug Administration and/or a full approval. The majority of the vaccines in development have received funding from the U.S. government, either to help support clinical development or pay for manufacturing and distribution of the vaccines as part of the Trump administration's Operation Warp Speed program. \n</p>\n<p>\n  MarketWatch will update this tally as the vaccines move through development. \n</p>\n<p>\n  Vaccines that have entered Phase 3 trials in the U.S. (cited in alphabetical order, by company name): \n</p>\n<p>\n  AstraZeneca, in partnership with the University of Oxford \n</p>\n<p>\n  Year-to-date stock performance:(AZN.LN) (AZN.LN) Up 7.8% \n</p>\n<p>\n  Name: AZD1222 \n</p>\n<p>\n  Type: Vector-based \n</p>\n<p>\n  Phase 1/2: Data from the Phase 1/2 trial, which is being conducted in the U.K., was published July 20 in The Lancet  neutralizing antibody responses in 91% of 35 patients when using <a href=\"https://laohu8.com/S/AONE.U\">one</a> test and 100% of 35 patients when using a different test. \n</p>\n<p>\n  Phase 3: This trial, which will be held in the U.S., is expected to enroll up to 30,000 participants. (Late-stage studies are also being conducted in Brazil, and South Africa, and the U.K.) Data is expected by the end of the year. \n</p>\n<p>\n  Clinical development and manufacturing funding from the U.S. government: up to $1.2 billion \n</p>\n<p>\n  U.S. dose promise: 300 million doses \n</p>\n<p>\n  Dosing: 2 doses \n</p>\n<p>\n  BioNTech  and Pfizer Inc. \n</p>\n<p>\n  Year-to-date stock performances: BioNTech<a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a>, up 75.0%; Pfizer<a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a>, down 8.3%. \n</p>\n<p>\n  Name: BNT162b2 \n</p>\n<p>\n  Type: mRNA \n</p>\n<p>\n  Phase 1: The companies published preliminary data on July 1 for BNT162b1 as a preprint  was published on Aug. 28 for BNT162b2 that found this candidate produced similar levels of antibodies but participants reported fewer reactions. \n</p>\n<p>\n    This trial is expected to focus on BNT162b2. It is expected to enroll up to 30,000 participants in Argentina, Brazil, and the U.S. \n</p>\n<p>\n  Manufacturing funding from the U.S. government: $1.95 billion \n</p>\n<p>\n  U.S. dose promise: 100 million doses, with option to buy up to 500 million more doses \n</p>\n<p>\n  Dosing: 2 doses \n</p>\n<p>\n  Moderna Inc. \n</p>\n<p>\n  Year-to-date stock performance:<a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> Up 187.8% \n</p>\n<p>\n  Name: mRNA-1273 \n</p>\n<p>\n  Type: mRNA \n</p>\n<p>\n  Phase 1 . Moderna's vaccine candidate elicited neutralizing antibodies in all 45 participants in this trial, which was conducted in the U.S. in partnership with the National Institute of Allergy and Infectious Diseases. \n</p>\n<p>\n  Phase 2a : This study closed enrollment of 600 participants on July 8. This trial is also focused on the U.S. \n</p>\n<p>\n  Phase 3 : This study is expected to complete enrollment of up to 30,000 people sometime in September. \n</p>\n<p>\n  R&amp;D funding from BARDA: $955 million \n</p>\n<p>\n  Supply funding from the U.S. government: Up to $1.525 billion \n</p>\n<p>\n  U.S. dose promise: 100 million, with option to acquire up 400 million additional doses \n</p>\n<p>\n  Dosing: 2 doses \n</p>\n<p>\n  Vaccines that have entered Phase 1 and 2 trials in the U.S. (cited in alphabetical order, by company name): \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/INO\">Inovio Pharmaceuticals Inc</a>. \n</p>\n<p>\n  Year-to-date stock performance:(INO)up 191.2% \n</p>\n<p>\n  Name: INO-4800 \n</p>\n<p>\n  Type: DNA \n</p>\n<p>\n  Phase 1  on June; it has not yet shared the full data but has submitted the results for publication in a peer-reviewed medical journal. The trial is being conducted in the U.S. \n</p>\n<p>\n  Phase 2/3: Inovio said Sept. 8 it plans to launch this phase of the study in September, if it is given the go-ahead by the FDA. \n</p>\n<p>\n  U.S. government funding: It received $71 million  from the Department of Defense to make and buy the devices that will be used to dispense the company's vaccine if it is authorized or approved. \n</p>\n<p>\n  Johnson &amp; Johnson \n</p>\n<p>\n  Year-to-date stock performance:<a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> Up 1.2% \n</p>\n<p>\n  Name: Ad26. COV2. S \n</p>\n<p>\n  Type: Vector-based \n</p>\n<p>\n  Phase 1/2a  in the second half of July, with a goal of enrolling 1,045 adults in Belgium and the U.S. \n</p>\n<p>\n  Phase 3: It plans to launch this trial in September. \n</p>\n<p>\n  R&amp;D funding from BARDA: $456 million \n</p>\n<p>\n  U.S. government funding for manufacturing and delivery:More than $1 billion  \n</p>\n<p>\n  U.S. dose promise: 100 million doses, with option to buy up to 200 million additional doses \n</p>\n<p>\n  Novavax Inc. \n</p>\n<p>\n  Year-to-date stock performance:<a href=\"https://laohu8.com/S/NVAX\">$(NVAX)$</a> Up 2,167.6% \n</p>\n<p>\n  Name: NVX-CoV2373 \n</p>\n<p>\n  Type: Protein subunit \n</p>\n<p>\n  Phase 1: . \n</p>\n<p>\n  Phase 1/2: The second phase of the Phase 1/2 trial started in August and will be conducted in Australia and the U.S. \n</p>\n<p>\n  Phase 3: TBD \n</p>\n<p>\n  Clinical development and manufacturing funding from the U.S. government:$1.6 billion  \n</p>\n<p>\n  U.S. dose promise: 100 million doses \n</p>\n<pre><table><tbody><tr><td></td><td>Sanofi</td><td>in combination with GlaxoSmithKline's (TICKER:GSK) (TICKER:UK:GSK)</td><td>adjuvant technology </td></tr></tbody></table></pre>\n<p>\n  Companies: \n</p>\n<p>\n  Year-to-date stock performance: Sanofi (SAN.FR)(SAN.FR) Up 0.6%. \n</p>\n<p>\n  Name: TBD \n</p>\n<p>\n  Type: Protein-based \n</p>\n<p>\n  Phase 1/2 study: The trial was initiated Sept. 3 , with a goal of enrolling 440 adults in the U.S. Results are expected in December. \n</p>\n<p>\n  Phase 3: This study is expected to launch by the \"end of 2020.\" \n</p>\n<p>\n  Clinical development and manufacturing funding from the U.S. government: Up to $2.1 billion \n</p>\n<p>\n  U.S. dose promise: Up to 100 million doses, with option to buy up to 500 million doses \n</p>\n<pre><table><tbody><tr><td>Sources: Company websites, federal data, the World Health Organization, RBC Capital Markets </td></tr></tbody></table></pre>\n<p>\n  -Jaimy Lee; 415-439-6400; AskNewswires@dowjones.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 08, 2020 13:37 ET (17:37 GMT)\n</p>\n<p>\n  Copyright (c) 2020 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"INO":"伊诺维奥制药","JNJ":"强生","MRNA":"Moderna, Inc.","AZN":"阿斯利康","SNY":"赛诺菲安万特","PFE":"辉瑞","NVAX":"诺瓦瓦克斯医药","GSK.UK":"葛兰素史克","GSK":"葛兰素史克","BNTX":"BioNTech SE"},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2066210025","content_text":"MW UPDATE: There are seven coronavirus vaccine candidates being tested in the U.S. -- here's where they stand\n\n\n  By Jaimy Lee \n\n\n  At least three of the still investigational vaccines have moved into Phase 3 clinical trials \n\n\n  The race to develop a safe and effective COVID-19 vaccine is well under way, setting the stage to bring to market the fastest vaccine in history. \n\n\n  There are dozens of coronavirus vaccines in development, primarily in the preclinical phase when they are tested on animals. In the U.S., there are seven vaccine candidates that have moved into clinical trials with human participants, including three that have moved into the crucial Phase 3 development phase. \n\n\n  The first and second phases of clinical studies are primarily conducted to test for safety, while the third and final stage is used to determine whether the vaccines are efficacious and can prevent infection among participants. At that point, the vaccine makers will decide when to pursue an emergency use authorization from the Food and Drug Administration and/or a full approval. The majority of the vaccines in development have received funding from the U.S. government, either to help support clinical development or pay for manufacturing and distribution of the vaccines as part of the Trump administration's Operation Warp Speed program. \n\n\n  MarketWatch will update this tally as the vaccines move through development. \n\n\n  Vaccines that have entered Phase 3 trials in the U.S. (cited in alphabetical order, by company name): \n\n\n  AstraZeneca, in partnership with the University of Oxford \n\n\n  Year-to-date stock performance:(AZN.LN) (AZN.LN) Up 7.8% \n\n\n  Name: AZD1222 \n\n\n  Type: Vector-based \n\n\n  Phase 1/2: Data from the Phase 1/2 trial, which is being conducted in the U.K., was published July 20 in The Lancet  neutralizing antibody responses in 91% of 35 patients when using one test and 100% of 35 patients when using a different test. \n\n\n  Phase 3: This trial, which will be held in the U.S., is expected to enroll up to 30,000 participants. (Late-stage studies are also being conducted in Brazil, and South Africa, and the U.K.) Data is expected by the end of the year. \n\n\n  Clinical development and manufacturing funding from the U.S. government: up to $1.2 billion \n\n\n  U.S. dose promise: 300 million doses \n\n\n  Dosing: 2 doses \n\n\n  BioNTech  and Pfizer Inc. \n\n\n  Year-to-date stock performances: BioNTech$(BNTX)$, up 75.0%; Pfizer$(PFE)$, down 8.3%. \n\n\n  Name: BNT162b2 \n\n\n  Type: mRNA \n\n\n  Phase 1: The companies published preliminary data on July 1 for BNT162b1 as a preprint  was published on Aug. 28 for BNT162b2 that found this candidate produced similar levels of antibodies but participants reported fewer reactions. \n\n\n    This trial is expected to focus on BNT162b2. It is expected to enroll up to 30,000 participants in Argentina, Brazil, and the U.S. \n\n\n  Manufacturing funding from the U.S. government: $1.95 billion \n\n\n  U.S. dose promise: 100 million doses, with option to buy up to 500 million more doses \n\n\n  Dosing: 2 doses \n\n\n  Moderna Inc. \n\n\n  Year-to-date stock performance:$(MRNA)$ Up 187.8% \n\n\n  Name: mRNA-1273 \n\n\n  Type: mRNA \n\n\n  Phase 1 . Moderna's vaccine candidate elicited neutralizing antibodies in all 45 participants in this trial, which was conducted in the U.S. in partnership with the National Institute of Allergy and Infectious Diseases. \n\n\n  Phase 2a : This study closed enrollment of 600 participants on July 8. This trial is also focused on the U.S. \n\n\n  Phase 3 : This study is expected to complete enrollment of up to 30,000 people sometime in September. \n\n\n  R&D funding from BARDA: $955 million \n\n\n  Supply funding from the U.S. government: Up to $1.525 billion \n\n\n  U.S. dose promise: 100 million, with option to acquire up 400 million additional doses \n\n\n  Dosing: 2 doses \n\n\n  Vaccines that have entered Phase 1 and 2 trials in the U.S. (cited in alphabetical order, by company name): \n\n\nInovio Pharmaceuticals Inc. \n\n\n  Year-to-date stock performance:(INO)up 191.2% \n\n\n  Name: INO-4800 \n\n\n  Type: DNA \n\n\n  Phase 1  on June; it has not yet shared the full data but has submitted the results for publication in a peer-reviewed medical journal. The trial is being conducted in the U.S. \n\n\n  Phase 2/3: Inovio said Sept. 8 it plans to launch this phase of the study in September, if it is given the go-ahead by the FDA. \n\n\n  U.S. government funding: It received $71 million  from the Department of Defense to make and buy the devices that will be used to dispense the company's vaccine if it is authorized or approved. \n\n\n  Johnson & Johnson \n\n\n  Year-to-date stock performance:$(JNJ)$ Up 1.2% \n\n\n  Name: Ad26. COV2. S \n\n\n  Type: Vector-based \n\n\n  Phase 1/2a  in the second half of July, with a goal of enrolling 1,045 adults in Belgium and the U.S. \n\n\n  Phase 3: It plans to launch this trial in September. \n\n\n  R&D funding from BARDA: $456 million \n\n\n  U.S. government funding for manufacturing and delivery:More than $1 billion  \n\n\n  U.S. dose promise: 100 million doses, with option to buy up to 200 million additional doses \n\n\n  Novavax Inc. \n\n\n  Year-to-date stock performance:$(NVAX)$ Up 2,167.6% \n\n\n  Name: NVX-CoV2373 \n\n\n  Type: Protein subunit \n\n\n  Phase 1: . \n\n\n  Phase 1/2: The second phase of the Phase 1/2 trial started in August and will be conducted in Australia and the U.S. \n\n\n  Phase 3: TBD \n\n\n  Clinical development and manufacturing funding from the U.S. government:$1.6 billion  \n\n\n  U.S. dose promise: 100 million doses \n\nSanofiin combination with GlaxoSmithKline's (TICKER:GSK) (TICKER:UK:GSK)adjuvant technology \n\n  Companies: \n\n\n  Year-to-date stock performance: Sanofi (SAN.FR)(SAN.FR) Up 0.6%. \n\n\n  Name: TBD \n\n\n  Type: Protein-based \n\n\n  Phase 1/2 study: The trial was initiated Sept. 3 , with a goal of enrolling 440 adults in the U.S. Results are expected in December. \n\n\n  Phase 3: This study is expected to launch by the \"end of 2020.\" \n\n\n  Clinical development and manufacturing funding from the U.S. government: Up to $2.1 billion \n\n\n  U.S. dose promise: Up to 100 million doses, with option to buy up to 500 million doses \n\nSources: Company websites, federal data, the World Health Organization, RBC Capital Markets \n\n  -Jaimy Lee; 415-439-6400; AskNewswires@dowjones.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 08, 2020 13:37 ET (17:37 GMT)\n\n\n  Copyright (c) 2020 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1231,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}